10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended	March 31, 2023

Or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ______

Commission File Number: 001-35419

KAMAN CORPORATION

(Exact name of registrant as specified in its charter)

Connecticut	06-0613548
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1332 Blue Hills Avenue,	Bloomfield,	Connecticut	06002
(Address of principal executive offices)			(Zip Code)

(860)	243-7100
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock ($1 par value)	KAMN	New York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐	Non-accelerated filer	☐
		Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

At April 28, 2023, there were 28,175,986  shares of Common Stock outstanding.

PART I

Item 1. Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands, except share and per share amounts) (Unaudited)

	March 31, 2023		December 31, 2022
Assets
Current assets:
Cash and cash equivalents	$	53,986	$	24,154
Accounts receivable, net	101,292		87,659
Contract assets	116,168		113,182
Inventories	186,495		176,468
Income tax refunds receivable	1,321		13,981
Other current assets	22,975		16,114
Total current assets	482,237		431,558
Property, plant and equipment, net of accumulated depreciation of $274,458 and $268,089, respectively	203,266		201,606
Operating right-of-use assets, net	6,618		7,391
Goodwill	382,504		379,854
Other intangible assets, net	365,427		372,331
Deferred income taxes	47,818		47,385
Other assets	50,788		51,207
Total assets	$	1,538,658	$	1,491,332
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable – trade	$	47,194	$	48,277
Accrued salaries and wages	26,258		31,395
Contract liabilities, current portion	6,044		4,081
Operating lease liabilities, current portion	3,121		3,332
Income taxes payable	170		393
Other current liabilities	44,210		39,097
Total current liabilities	126,997		126,575
Long-term debt, excluding current portion, net of debt issuance costs	609,325		561,061
Deferred income taxes	6,365		6,079
Underfunded pension	51,459		52,309
Contract liabilities, noncurrent portion	20,329		20,515
Operating lease liabilities, noncurrent portion	3,905		4,534
Other long-term liabilities	36,322		36,280
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock, $1 par value, 200,000 shares authorized; none outstanding	—		—
Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,766,419 and 30,640,068 shares issued, respectively	30,766		30,640
Additional paid-in capital	247,812		245,436
Retained earnings	682,812		688,457
Accumulated other comprehensive income (loss)	(154,793)		(158,421)
Less 2,632,334 and 2,607,841 shares of common stock, respectively, held in treasury, at cost	(122,641)		(122,133)
Total shareholders’ equity	683,956		683,979
Total liabilities and shareholders’ equity	$	1,538,658	$	1,491,332

See accompanying notes to condensed consolidated financial statements.

2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands, except per share amounts) (Unaudited)

	For the Three Months Ended
	March 31, 2023		April 1, 2022
Net sales	$	194,542	$	158,048
Cost of sales	126,998		107,461
Gross profit	67,544		50,587
Selling, general and administrative expenses	43,698		39,721
Research and development costs	5,907		5,113
Intangible asset amortization expense	7,152		2,467
Restructuring and severance costs	2,190		169
Net (gain) loss on sale of assets	(31)		60
Operating income	8,628		3,057
Interest expense, net	9,604		2,481
Non-service pension and post-retirement benefit income	(381)		(5,263)
Other (income) expense, net	(571)		504
(Loss) earnings before income taxes	(24)		5,335
Income tax (benefit) expense	(5)		1,307
Net (loss) earnings	$	(19)	$	4,028
Earnings (loss) per share:
Basic (loss) earnings per share	$	(0.00)	$	0.14
Diluted (loss) earnings per share	$	(0.00)	$	0.14
Average shares outstanding:
Basic	28,117		27,950
Diluted	28,117		28,082

See accompanying notes to condensed consolidated financial statements.

3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands) (Unaudited)

	For the Three Months Ended
	March 31, 2023		April 1, 2022
Net (loss) earnings	$	(19)	$	4,028
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	2,538		(5,218)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $434 and $228, respectively	1,441		762
Loss on derivative instruments, net of tax benefit of $106 and $0, respectively	(351)		—
Other comprehensive income (loss)	3,628		(4,456)
Comprehensive income (loss)	$	3,609	$	(428)

See accompanying notes to condensed consolidated financial statements.

4

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands) (Unaudited)

	For the Three Months Ended
	March 31, 2023		April 1, 2022
Cash flows from operating activities:
Net (loss) earnings	$	(19)	$	4,028
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	13,154		8,832
Amortization of debt issuance costs	883		442
Provision for doubtful accounts	805		135
Net (gain) loss on sale of assets	(31)		60
Net (gain) loss on derivative instruments	(283)		449
Stock compensation expense	2,003		2,081
Deferred income taxes	(669)		(1,247)
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
Accounts receivable	(14,177)		4,307
Contract assets	(2,973)		12,973
Inventories	(9,596)		(17,285)
Income tax refunds receivable	12,663		(410)
Operating right of use assets	785		915
Other assets	(6,431)		(2,105)
Accounts payable - trade	(1,151)		(612)
Contract liabilities	1,776		(137)
Operating lease liabilities	(852)		(899)
Other current liabilities	(2,483)		(10,581)
Income taxes payable	(222)		53
Pension liabilities	936		(1,876)
Other long-term liabilities	429		(140)
Net cash used in operating activities	(5,453)		(1,017)
Cash flows from investing activities:
Expenditures for property, plant & equipment	(5,948)		(6,877)
Acquisition of businesses	(1,487)		—
Other, net	(1,363)		424
Net cash used in investing activities	(8,798)		(6,453)
Cash flows from financing activities:
Borrowings under revolving credit agreement	94,000		—
Repayments under revolving credit agreement	(46,000)		—
Purchase of treasury shares	(503)		(575)
Dividends paid	(5,606)		(5,572)
Other, net	2,079		2,112
Net cash provided by (used in) financing activities	43,970		(4,035)
Net increase (decrease) in cash and cash equivalents	29,719		(11,505)
Effect of exchange rate changes on cash and cash equivalents	113		(198)
Cash and cash equivalents at beginning of period	24,154		140,800
Cash and cash equivalents at end of period	$	53,986	$	129,097

See accompanying notes to condensed consolidated financial statements.

5

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

1. BASIS OF PRESENTATION

In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The first quarters for 2023 and 2022 ended on March 31, 2023, and April 1, 2022, respectively.

2. BUSINESS COMBINATIONS AND INVESTMENTS

Aircraft Wheel & Brake

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker-Hannifin Corporation's ("Parker") Aircraft Wheel and Brake division, of Avon, Ohio, at a purchase price of $442.8 million. Aircraft Wheel and Brake is a leader in the design, development, qualification, manufacturing and assembly, product support and repair of wheels, brakes and related hydraulic components for fixed-wing aircraft and rotorcraft. With this acquisition, the Company has expanded its portfolio of engineered products, broadening the number of offerings available to serve customers across a range of critical applications and has increased the Company's exposure within the aerospace and defense end markets.

This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands):

Accounts receivable	$	7,635
Contract assets	171
Inventories	11,246
Property, plant and equipment	7,686
Goodwill	171,277
Other intangible assets(1)	250,500
Contract costs, noncurrent	41
Liabilities	(5,729)
Net assets acquired	442,827
Less cash received	—
Net consideration	$	442,827

(1)Refer to Note 3, Business Combinations and Investments, in the Annual Report on Form 10-K for the year ended December 31, 2022 for information on the Company's determination of the fair value of identifiable assets.

During the first quarter of 2023, the Company paid Parker an additional $1.5 million for the working capital adjustment, which resulted in an increase to goodwill. All purchase price allocations were finalized within the one-year measurement period and no further adjustments are expected.

The goodwill associated with this acquisition is tax deductible and is the result of expected synergies from combining the operations of the acquired business with the Company's operations and intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill associated with this acquisition was recognized in the Engineered Products segment.

Aircraft Wheel and Brake's results of operations have been included in the Company's financial statements for the period subsequent to the completion of the acquisition on September 16, 2022. Aircraft Wheel and Brake contributed $18.5 million of revenue and $0.8 million of operating income for the three-month fiscal period ended March 31, 2023.

6

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

3. REVENUE AND SEGMENT INFORMATION

The Company is organized based upon the nature of its products and services, and is composed of three operating segments, each overseen by a segment manager. These segments are reflective of how the Company’s Chief Executive Officer, who is its Chief Operating Decision Maker ("CODM"), reviews operating results for the purposes of allocating resources and assessing performance. The Company has not aggregated operating segments for purposes of identifying reportable segments.

The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters and fixed-wing and unmanned aerial vehicle ("UAV") aircraft.

The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; support of the heavy lift K-MAX® manned helicopter; and development of the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.

Summarized financial information by business segment is as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Net sales:
Engineered Products	$	123,326	$	81,452
Precision Products	37,971		47,549
Structures	33,245		29,047
Net sales	$	194,542	$	158,048
Operating income (loss):
Engineered Products	$	19,356	$	11,042
Precision Products	1,674		3,409
Structures	(237)		(617)
Corporate expense	(10,006)		(10,548)
Other unallocated expenses, net(1)	(2,159)		(229)
Operating income	$	8,628	$	3,057
Interest expense, net	9,604		2,481
Non-service pension and post retirement benefit income, net	(381)		(5,263)
Other (income) expense, net	(571)		504
(Loss) earnings before income taxes	$	(24)	$	5,335

(1) Other unallocated expenses, net include restructuring and severance costs and net (gain) loss on sale of assets.

7

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

3. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue

The following tables disaggregate segment revenue by major product line:

	For the Three Months Ended
	March 31, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	20,023	$	5,586	$	18,805	$	44,414
Safe and Arm Devices	—		26,242		—		26,242
Commercial, Business & General Aviation	59,685		5,013		12,504		77,202
Medical	24,935		—		1,936		26,871
Industrial & Other	18,683		1,130		—		19,813
Total revenue	$	123,326	$	37,971	$	33,245	$	194,542
	For the Three Months Ended
	April 1, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	9,653	$	5,322	$	16,255	$	31,230
Safe and Arm Devices	—		37,322		—		37,322
Commercial, Business & General Aviation	32,378		3,767		10,813		46,958
Medical	21,149		—		1,979		23,128
Industrial & Other	18,272		1,138		—		19,410
Total revenue	$	81,452	$	47,549	$	29,047	$	158,048

The following table disaggregates total revenue by product types.

	For the Three Months Ended
	March 31, 2023
	Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	45	%	2	%	17	%	64	%
Aftermarket	18	%	5	%	—	%	23	%
Safe and Arm Devices	—	%	13	%	—	%	13	%
Total revenue	63	%	20	%	17	%	100	%
	For the Three Months Ended
	April 1, 2022
	Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	41	%	2	%	18	%	61	%
Aftermarket	11	%	4	%	—	%	15	%
Safe and Arm Devices	—	%	24	%	—	%	24	%
Total revenue	52	%	30	%	18	%	100	%

8

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

3. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Research and Development Costs

The following table presents research and development costs by segment:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Engineered Products	$	2,439	$	2,243
Precision Products	3,458		2,803
Structures	10		67
Total research and development costs	$	5,907	$	5,113

Other

For contracts in which revenue is recognized over time, the Company performs detailed quarterly reviews of the progress and execution of its performance obligations under these contracts. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and cost to achieve the schedule (e.g., the number and type of milestone events), technical requirements (e.g., a newly-developed product versus a mature product) and other contract requirements. Management must make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation (e.g., to estimate increases in wages and prices for materials and related support cost allocations), execution by subcontractors, the availability and timing of funding from customers and overhead cost rates, among other variables. Based upon these reviews, the Company will record the effects of adjustments in profit estimates each period. If at any time management determines that in the case of a particular contract total costs will exceed total contract revenue, a provision for the entire anticipated contract loss is recorded at that time.

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Net (decrease) increase in revenue due to change in profit estimates	$	(1,269)	$	905

In the three-month fiscal period ended March 31, 2023, the net decrease in revenue was primarily related to cost growth on certain structures and precision products contracts, partially offset by favorable cost performance on the joint programmable fuze ("JPF") contract with the U.S. Government ("USG") and the JASSM contract. In the three-month fiscal period ended April 1, 2022, the net increase in revenue was primarily related to favorable cost performance on the JPF contract with the USG, partially offset by cost growth on certain structures programs and legacy fuzing contracts.

9

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

3. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Unfulfilled Performance Obligations

Unfulfilled performance obligations ("backlog") represents the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts. Backlog at March 31, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows:

	March 31, 2023(1)		December 31, 2022
	(in thousands)
Engineered Products	$	369,713	$	322,452
Precision Products	111,750		134,903
Structures	251,531		263,581
Total Backlog	$	732,994	$	720,936

(1) The Company expects to recognize revenue on approximately 73% of backlog as of March 31, 2023 over the next twelve months.

4. RESTRUCTURING AND SEVERANCE COSTS

Restructuring and severance costs are included in restructuring and severance costs on the Company's Condensed Consolidated Statements of Operations and other unallocated expenses, net within in Note 3, Revenue and Segment Information.

Transformation Restructuring

In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improve working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result of this review, the Company identified areas to reduce annualized costs in the Precision Products segment and at Corporate through streamlining processes, consolidating the production of fuzes for the JPF program at its Middletown facility, discontinuing K-MAX® helicopter production and right-sizing the Company's total cost structure. In the three-month fiscal period ended March 31, 2023, the Company incurred $2.2 million in severance costs associated with these actions. Of this amount, $0.3 million was related to share-based compensation expense.

The following table summarizes the accrual balances by cost type for the restructuring actions:

	Severance		Other(1)		Total
In thousands
Restructuring accrual balance at December 31, 2022(2)	$	6,629	$	—	$	6,629
Provision	1,730		136		1,866
Cash payments	(3,616)		(136)		(3,752)
Changes in foreign currency exchange rates	25		—		25
Restructuring accrual balance at March 31, 2023(2)	$	4,768	$	—	$	4,768

(1) Includes costs associated with the consolidation of facilities.

(2) Of the above accrual balance, $1.0 million was included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022. The remainder is included in other current liabilities.

10

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

5. ACCOUNTS RECEIVABLE, NET

Accounts receivable, net consisted of the following:

	March 31, 2023		December 31, 2022
In thousands
Trade receivables	$	41,989	$	31,126
U.S. Government contracts:
Billed	15,576		14,150
Cost and accrued profit - not billed	1,588		661
Commercial and other government contracts
Billed	42,615		41,520
Cost and accrued profit - not billed	2,268		2,268
Less allowance for doubtful accounts	(2,744)		(2,066)
Accounts receivable, net	$	101,292	$	87,659

The Company performs ongoing evaluations of its customers’ current creditworthiness, as determined by the review of their credit information, to determine if events have occurred subsequent to the recognition of revenue and the related receivable that provide evidence that such receivable will be realized in an amount less than that recognized at the time of sale. Estimates of credit losses are based on historical losses, current economic conditions, geographic considerations, and in some cases, evaluating specific customer accounts for risk of loss.

The following table summarizes the activity in the allowance for doubtful accounts in the three-month fiscal period ended March 31, 2023:

In thousands
Balance at December 31, 2022	$	(2,066)
Provision	(805)
Amounts written off	57
Recoveries	71
Changes in foreign currency exchange rates	(1)
Balance at March 31, 2023	$	(2,744)

There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

11

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

6. CONTRACT ASSETS, CONTRACT COSTS AND CONTRACT LIABILITIES

Activity related to contract assets, contract costs and contract liabilities was as follows:

	March 31, 2023		December 31, 2022		$ Change		% Change
In thousands
Contract assets	$	116,168	$	113,182	$	2,986	2.6	%
Contract costs, current portion(1)	$	531	$	695	$	(164)	(23.6)	%
Contract costs, noncurrent portion(2)	$	693	$	673	$	20	3.0	%
Contract liabilities, current portion	$	6,044	$	4,081	$	1,963	48.1	%
Contract liabilities, noncurrent portion	$	20,329	$	20,515	$	(186)	(0.9)	%

(1) Contract costs, current portion are included within other current assets on the Company's Condensed Consolidated Balance Sheets.

(2) Contract costs, noncurrent portion are included within other assets on the Company's Condensed Consolidated Balance Sheets.

Contract Assets

The increase in contract assets was primarily due to the recognition of revenue related to the satisfaction or partial satisfaction of performance obligations for work performed and not yet billed on certain programs with Boeing and the AH-1 blade program compared to lower amounts billed in the current period on the JPF program. There were no significant impairment losses related to the Company's contract assets during the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

There were no amounts included in contract assets for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

Contract Costs

At March 31, 2023 and December 31, 2022, costs to fulfill a contract were $1.2 million and $1.4 million, respectively. These amounts were included in other current assets and other assets on the Company's Condensed Consolidated Balance Sheets at March 31, 2023 and December 31, 2022. There were no costs to obtain a contract at March 31, 2023 and December 31, 2022.

Contract costs, current portion at March 31, 2023 decreased compared to the balance at December 31, 2022. This was primarily attributable to the amortization of contract costs. Amortization of contract costs was $0.1 million for the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Contract costs, noncurrent portion at March 31, 2023 remained relatively flat when compared to the balance at December 31, 2022.

Contract Liabilities

Contract liabilities, current portion at March 31, 2023 increased compared to the balance at December 31, 2022. This was primarily due to advances received for the SH-2G program with New Zealand and the reclassification of liabilities on the FireburstTM enhanced fuzing capability program from contract liabilities, noncurrent portion, partially offset by revenue recognized on the JASSM® program. Revenue recognized related to contract liabilities, current portion was $0.5 million in the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Contract liabilities, noncurrent portion at March 31, 2023 decreased compared to the balance at December 31, 2022 due to the reclassification of liabilities on the FireBurstTM enhanced fuzing capability program to contract liabilities, current portion, partially offset by advances received for the JPF program. For the three-month fiscal periods ended March 31, 2023 and April 1, 2022, the Company did not recognize revenue against contract liabilities, noncurrent portion. Refer to Note 12, Commitments and Contingencies, for further information on the Company's offset agreements.

12

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

7. FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.

The Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: 

•Level 1 — Quoted prices in active markets for identical assets or liabilities.

•Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.

•Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table presents the carrying value and fair value of financial instruments that are not carried at fair value:

	March 31, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
In thousands
Debt (1)	$	610,500	$	592,533	$	562,500	$	547,393

(1) These amounts are classified within Level 2.

The above fair values were computed based on quoted market prices and discounted future cash flows (observable inputs), as applicable. Differences from carrying values are attributable to interest rate changes subsequent to when the transactions occurred.

The fair values of cash and cash equivalents, accounts receivable, net and accounts payable - trade approximate their carrying amounts due to the short-term maturities of these instruments. The Company's cash and cash equivalents at March 31, 2023 and December 31, 2022 included $35.1 million and $0.1 million, respectively, of Level 1 money market funds.

Recurring Fair Value Measurements

The Company holds derivative instruments for foreign exchange contracts and interest rate swaps that are measured at fair value using observable market inputs such as forward rates and its counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At March 31, 2023, the interest rate swaps were included in other current liabilities and other long-term liabilities on the Company's Condensed Consolidated Balance Sheets. At March 31, 2023 and December 31, 2022, the foreign exchange contracts were included in other current assets and other current liabilities on the Company's Condensed Consolidated Balance Sheets. Based on the Company's continued ability to trade and enter into forward contracts and interest rate swaps, the Company considers the markets for its fair value instruments to be active.

The Company evaluated the credit risk associated with the counterparties to these derivative instruments and determined that as of March 31, 2023, such credit risks had not had an adverse impact on the fair value of these instruments.

8. DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks relating to its ongoing business operations, including market risks relating to fluctuations in foreign currency exchange rates and interest rates. Derivative financial instruments are recognized on the Condensed Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair values of derivatives are recorded each period in earnings or accumulated other comprehensive income, depending on whether a derivative is effective as part of a hedged transaction. Gains and losses on derivative instruments reported in accumulated other comprehensive income (loss) are subsequently included in earnings in the periods in which earnings are affected by the hedged item. The Company does not use derivative instruments for speculative purposes.

13

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

8. DERIVATIVE FINANCIAL INSTRUMENTS (CONTINUED)

Cash Flow Hedges

Interest Rate Swaps

The Company's Credit Agreement (as defined in "Management's Discussion and Analysis of Financial Condition and Results of Operations" below) contains floating rate obligations and is subject to interest rate fluctuations. In late 2022, the Company entered into interest rate swap agreements with a notional value of $200.0 million, effective January 1, 2023, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These interest rate swap agreements were designated as cash flow hedges and intended to manage interest rate risk associated with the Company's variable-rate borrowings and minimize the impact on earnings and cash flows of interest rate fluctuations attributable to changes in the Secured Overnight Financing Rate. These interest rate swaps were not material to the Company's Condensed Consolidated Financial Statements for the three-month fiscal period ended March 31, 2023. Over the next twelve months, the income related to cash flow hedges expected to be reclassified from other comprehensive income is $0.3 million.

Forward Exchange Contracts

The Company holds forward exchange contracts designed to hedge forecasted transactions denominated in foreign currencies and to minimize the impact of foreign currency fluctuations on the Company’s earnings and cash flows. These contracts were not material to the Company's Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022. The activity related to these contracts was not material to the Company's Condensed Consolidated Financial Statements for the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

9. INVENTORIES

Inventories consisted of the following:

	March 31, 2023		December 31, 2022
In thousands
Raw materials	$	27,595	$	25,798
Contracts and other work in process (including certain general stock materials)	124,953		110,609
Finished goods	33,947		40,061
Inventories	$	186,495	$	176,468

There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

At March 31, 2023 and December 31, 2022, $25.6 million and $24.7 million, respectively, of K-MAX® inventory was included in contracts and other work in process inventory and finished goods on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $23.4 million of the K-MAX® inventory will be sold after March 31, 2024, based upon the requirements to support the fleet for the foreseeable future. In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improving working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result, the Company determined it would discontinue K-MAX® aircraft production and wrote off $44.5 million of inventory associated with the program as of December 31, 2022. There were no additional inventory write-offs for the period ended March 31, 2023; however, production material for the K-MAX® includes long lead parts, which the Company evaluates for alternative use as received. Any write-offs related to these parts are not expected to have a material adverse effect on the Company's results of operations or financial position.

At March 31, 2023 and December 31, 2022, $6.4 million and $6.2 million, respectively, of SH-2G(I) inventory was included in contracts and other work in process inventory on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $5.3 million of the SH-2G(I) inventory will be sold after March 31, 2024. This balance represents spares requirements and inventory to be used on SH-2G programs.

14

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

10. GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company:

	Engineered Products		Precision Products		Structures		Total
In thousands
Gross balance at December 31, 2022	$	363,785	$	41,375	$	66,559	$	471,719
Accumulated impairment	—		(25,306)		(66,559)		(91,865)
Net balance at December 31, 2022	363,785		16,069		—		379,854
Additions	1,487		—		—		1,487
Impairments	—		—		—		—
Foreign currency translation	1,163		—		—		1,163
Ending balance at March 31, 2023	$	366,435	$	16,069	$	—	$	382,504
Accumulated impairment at end of period	$	—	$	(25,306)	$	(66,559)	$	(91,865)

Other Intangible Assets

Other intangible assets consisted of:

		At March 31,				At December 31,
		2023				2022
	Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
In thousands
Customer lists / relationships	6-38 years	$	363,846	$	(45,025)	$	363,549	$	(41,695)
Developed technologies	7-20 years	45,139		(18,615)		45,028		(17,508)
Trademarks / trade names	15-40 years	16,747		(3,339)		16,681		(3,153)
Non-compete agreements and other	1-15 years	17,356		(10,745)		17,336		(7,974)
Patents	17 years	551		(488)		551		(484)
Total intangible assets		$	443,639	$	(78,212)	$	443,145	$	(70,814)

11. PENSION PLANS

Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows:

	For the Three Months Ended
	Qualified Pension Plan				SERP
	March 31, 2023		April 1, 2022		March 31, 2023		April 1, 2022
In thousands
Service cost	$	1,450	$	800	$	—	$	—
Interest cost on projected benefit obligation	7,250		4,250		44		22
Expected return on plan assets	(9,550)		(10,525)		—		—
Amortization of net loss	1,875		975		—		15
Net pension cost (income)	$	1,025	$	(4,500)	$	44	$	37

15

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

11. PENSION PLANS (CONTINUED)

No contributions are expected to be made to the qualified pension plan during 2023. The Company contributed $0.1 million to the SERP through the end of the first quarter of 2023 and plans to contribute an additional $0.4 million to the SERP in 2023. No contributions were made to the qualified pension plan during 2022. For the 2022 plan year, the Company contributed $0.5 million to the SERP.

12. COMMITMENTS AND CONTINGENCIES

New Hartford Property

In connection with the sale of the Company’s Music segment in 2007, the Company assumed responsibility for meeting certain requirements of the Connecticut Transfer Act (the “Transfer Act”) that applied to the transfer of the New Hartford, Connecticut, facility leased by that segment for guitar manufacturing purposes (“Ovation”). Under the Transfer Act, those responsibilities essentially consist of assessing the site's environmental conditions and remediating environmental impairments, if any, caused by Ovation's operations prior to the sale. The site is a multi-tenant industrial park, in which Ovation and other unrelated entities lease space. The environmental assessment process, which began in 2008, has been completed and site remediation is in process.

The Company's estimate of its portion of the cost to assess the environmental conditions and remediate this site is $2.3 million, all of which has been accrued. The remediation has been nearly completed and the Company continues to monitor the results of the remediation. The total amount paid to date in connection with these environmental remediation activities is $1.8 million. At March 31, 2023, the Company had $0.5 million accrued for these environmental remediation activities. A portion ($0.1 million) of the accrual related to this property is included in other current liabilities and the balance is included in other long-term liabilities. The remaining balance of the accrual reflects the total anticipated cost of completing these environmental remediation activities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

Bloomfield Property

In connection with the Company’s 2008 purchase of the portion of the Bloomfield campus that Kaman Aerospace Corporation had leased from NAVAIR, the Company assumed responsibility for environmental remediation at the facility as may be required under the Transfer Act and is currently remediating the property under the guidance of the Connecticut Department of Environmental Protection. The assumed environmental liability of $10.3 million was determined by taking the undiscounted estimated remediation liability of $20.8 million and discounting it at a rate of 8%. This remediation process will take many years to complete. The total amount paid to date in connection with these environmental remediation activities is $15.4 million. At March 31, 2023, the Company had $2.1 million accrued for these environmental remediation activities. A portion ($0.2 million) of the accrual related to this property is included in other current liabilities, and the balance is included in other long-term liabilities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

Offset Agreement

The Company has entered into offset agreements as a condition to obtaining orders from a Middle Eastern customer for the Company's JPF product. Offset agreements are designed to return economic value to the foreign country by requiring the Company to engage in activities supporting local defense or commercial industries, promoting a balance of trade, developing in-country technology capabilities or addressing other local development priorities. Such agreements may be satisfied through activities that do not require a direct cash payment, including transferring technology, providing manufacturing, training and other consulting support to in-country projects and the purchase by third parties of supplies from in-country vendors. The agreements may also be satisfied through the Company's use of cash for activities, such as subcontracting with local partners, purchasing supplies from in-country vendors, providing financial support for in-country projects and making investments in local ventures. At March 31, 2023, the aggregate amount of the Company's offset agreements had an outstanding notional value of approximately $220.9 million, which is equal to sixty percent of the contract value as defined by the agreement between the customer and the Company. The amount ultimately applied against offset agreements is based on negotiations with the customer and may require cash outlays that represent only a fraction of the notional value in the offset agreement.

16

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

12. COMMITMENTS AND CONTINGENCIES (CONTINUED)

Offset Agreement - continued

The Company continues to work with the customer to further define the requirements to satisfy the offset agreements. In February 2023, the Company announced that it received a Business Plan Approval Letter to establish a manufacturing and final assembly facility in collaboration with an in-country vendor, which will enhance the technological capabilities available in this country. Offset programs typically extend over several years and may provide for penalties in the event the Company fails to perform according to offset requirements. The satisfaction of the offset requirements will be determined by the customer. In the event the offset requirements of the contract are not met, the Company could be liable for potential penalties up to $18.8 million payable to the customer. Failure to satisfy the offset requirements could also negatively impact the Company's ability to attract future orders from this customer. The Company considers these potential penalties to be a reduction to the transaction price in its determination of the value of the performance obligations within these contracts. At March 31, 2023, $18.8 million in contract liabilities associated with the potential penalties of the offset requirements were included on the Company's Condensed Consolidated Balance Sheets.

Guarantees

During 2020, the Company and the USG entered into a Guaranty Agreement, pursuant to which the Company agreed to guarantee the full, complete and satisfactory performance of its subsidiary, Kaman Precision Products, Inc. ("KPPI") under all current and future contracts with the USG. As of the date of this filing, the only contract in place between KPPI and the USG relates to the production and sale of the JPF. KPPI is currently fulfilling the requirements of Option 16. The guarantee was provided in lieu of a periodic financial capability review by the Financial Capacity Team ("FCT") of the Defense Contract Management Agency ("DCMA"). The Company is unable to estimate the maximum potential amount of future payments under the guarantee as it is dependent on costs incurred by the USG in the event of default. Although the Company believes the risk of default is low given the maturity and operational performance of the JPF program, there can be no assurance that the guarantee will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker's Aircraft Wheel and Brake division. In association with the acquisition, the Company entered into a novation agreement in which Parker's contractual obligations with respect to Aircraft Wheel and Brake at the time of the acquisition were transferred to the Company. There can be no assurance that this agreement will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

17

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

13. COMPUTATION OF EARNINGS PER SHARE

The computation of basic earnings per share is based on net earnings divided by the weighted average number of shares of common stock outstanding for each period. The computation of diluted earnings per share reflects the common stock equivalency of dilutive options granted to employees under the Company's stock incentive plan, shares issuable on redemption of its convertible notes and shares issuable upon redemption of outstanding warrants.

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands, except per share amounts
Net (loss) earnings	$	(19)	$	4,028
Basic:
Weighted average number of shares outstanding	28,117		27,950
Basic (loss) earnings per share	$	(0.00)	$	0.14
Diluted:
Weighted average number of shares outstanding	28,117		27,950
Weighted average shares issuable on exercise of dilutive stock options	—		132
Total	28,117		28,082
Diluted (loss) earnings per share	$	(0.00)	$	0.14

Equity awards

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022, respectively, 698,648 and 645,403 shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods.

All outstanding stock awards were excluded in the computation of diluted earnings per share in the three-month fiscal period ended March 31, 2023 because their effect was antidilutive due to the net loss. For the three-month fiscal periods ended March 31, 2023, an additional 149,699 shares issuable under equity awards, which would have been dilutive if exercised based on the average market price being higher than the exercise price, were excluded from the computation of diluted earnings per share as their effect was antidilutive due to the net loss.

2024 Convertible Notes

For both three-month fiscal periods ended March 31, 2023 and April 1, 2022, 3,056,879 shares issuable under Convertible Notes due 2024 were excluded from the diluted earnings per share calculation because their effect was antidilutive.

14. SHARE-BASED ARRANGEMENTS

The Company accounts for stock options, restricted stock awards ("RSAs"), restricted stock units ("RSUs") and performance stock units ("PSUs") as equity awards and measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the statement of operations. The Company also has an employee stock purchase plan, which is accounted for as a liability award. Compensation expense for stock options, RSAs, RSUs and PSUs is recognized on a straight-line basis over the vesting period of the awards. Throughout the course of the vesting period, the Company monitors the achievement level for the return on invested capital ("ROIC") metric of the PSUs compared to the ROIC target and adjusts the number of shares expected to be earned, and the related compensation expense recorded thereafter, to reflect the most probable outcome. The PSUs granted in 2023 and 2022 assumed a 100% achievement level. Share-based compensation expense recorded for the three-month fiscal periods ended March 31, 2023 and April 1, 2022 was $2.0 million and $2.1 million, respectively. For the three-month fiscal period ended March 31, 2023, $0.3 million was recorded to restructuring and severance costs and the remaining amount was recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations.

18

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

14. SHARE-BASED ARRANGEMENTS (CONTINUED)

Stock option activity was as follows:

	For the Three Months Ended
	March 31, 2023
	Options	Weighted - average exercise price
Options outstanding at beginning of period	710,782	$	54.12
Granted	—	$	—
Exercised	—	$	—
Forfeited or expired	(24,061)	$	43.07
Options outstanding at March 31, 2023	686,721	$	54.51

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. No options were granted in the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Restricted stock award and restricted stock unit activity were as follows:

	For the Three Months Ended
	March 31, 2023
	Restricted  Stock	Weighted- average grant date fair value
Restricted Stock outstanding at beginning of period	159,521	$	45.78
Granted	102,600	$	25.24
Vested	(62,488)	$	47.14
Forfeited or expired	(4,366)	$	47.51
Restricted Stock outstanding at March 31, 2023	195,267	$	34.51

Performance stock unit activity was as follows:

	For the Three Months Ended
	March 31, 2023
	Performance Stock	Weighted- average grant date fair value
Performance Stock outstanding at beginning of period	172,144	$	60.44
Granted	178,385	$	32.03
Vested	—	$	—
Forfeited or expired	(30,345)	$	56.88
Performance Stock outstanding at March 31, 2023	320,184	$	44.95

The fair value of the PSUs based on total shareholder return ("TSR") was estimated on the date of grant using a Monte-Carlo simulation model. The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Three Months Ended
	March 31, 2023			April 1, 2022
Expected term (years)	2.9			2.9
Expected volatility	41.2		%	39.4		%
Risk-free interest rate	4.4		%	1.7		%
Expected dividend yield	3.3		%	1.9		%
Per share fair value of performance stock granted	$	38.83		$	68.10

19

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

15. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in shareholders’ equity for the three-month fiscal periods ended March 31, 2023, and April 1, 2022, were as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Beginning balance	$	683,979	$	796,329
Comprehensive income (loss)	3,609		(428)
Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	(5,627)		(5,590)
Employee stock plans and related tax benefit	495		785
Purchase of treasury shares	(503)		(575)
Share-based compensation expense	2,003		2,081
Impact of change in accounting standard(1)	—		(5,854)
Ending balance	$	683,956	$	786,748

(1) At January 1, 2022, the Company adopted Accounting Standard Update 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity" ("ASU 2020-06"). Refer to Note 1, Summary of Significant Accounting Policies, of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 for further information on the adoption of ASU 2020-06.

The components of accumulated other comprehensive income (loss) are shown below:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Foreign currency translation:
Beginning balance	$	(2,071)	$	8,765
Net gain (loss) on foreign currency translation	2,538		(5,218)
Other comprehensive income (loss), net of tax	2,538		(5,218)
Ending balance	$	467	$	3,547
Pension and other post-retirement benefits(1):
Beginning balance	$	(156,350)	$	(120,157)
Amortization of net loss, net of tax expense of $434 and $228, respectively	1,441		762
Other comprehensive income, net of tax	1,441		762
Ending balance	$	(154,909)	$	(119,395)
Derivative instruments(2):
Beginning balance	$	—	$	7
Loss on derivative instruments, net of tax benefit of $78 and $0, respectively	(260)		—
Reclassification to net income, net of tax benefit of $28 and $0, respectively	$	(91)	$	—
Other comprehensive (loss) income, net of tax	(351)		—
Ending balance	$	(351)	$	7
Total accumulated other comprehensive loss	$	(154,793)	$	(115,841)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 11, Pension Plans, for additional information.)

(2) See Note 8, Derivative Financial Instruments, for additional information regarding derivative instruments.

20

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022

(Unaudited)

16. INCOME TAXES

	For the Three Months Ended
	March 31, 2023		April 1, 2022
Effective Income Tax Rate	20.8	%	24.5	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings for the period. The decrease in the effective tax rate for the three-month period ended March 31, 2023 as compared to the corresponding rate in the prior year period was primarily driven by lower net earnings in the current period.

17. SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the issuance date of these financial statements. No material subsequent events were identified that require disclosure.

21

Item 2.         Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations is intended to provide readers of our condensed consolidated financial statements with the perspectives of management. It presents, in narrative and tabular form, information regarding our financial condition, results of operations, liquidity and certain other factors that may affect our future results, and is designed to enable the readers of this report to obtain an understanding of our businesses, strategies, current trends and future prospects. It should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Form 10-K") and the Condensed Consolidated Financial Statements included in Item 1 of this Form 10-Q.

OVERVIEW OF BUSINESS

Kaman Corporation ("the Company") conducts business through three business segments:

•The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated, proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters and fixed-wing and UAV aircraft.

•The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; support of the heavy lift K-MAX® manned helicopter; and development of the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

•The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.

Executive Summary

Consolidated net sales increased by 23.1% to $194.5 million compared to the prior year period, due to an 11.4% increase in organic sales and $18.5 million in sales from our Aircraft Wheel and Brake acquisition. Gross margin as a percentage of sales increased in the quarter to 34.7% compared to 32.0% in the prior year period, due to the addition of gross profit associated with our Aircraft Wheel and Brake acquisition and higher sales and improved performance on our K-MAX® spares and support. Selling, general and administrative expenses ("S,G&A") increased by 10.0% primarily due to the addition of S,G&A from Aircraft Wheel and Brake. Operating income in the period increased as a result of the drivers discussed above, partially offset by a $4.7 million increase in intangible asset amortization expense driven by the Aircraft Wheel and Brake acquisition and $2.0 million in higher restructuring and severance costs.

Other financial highlights

•There was a negligible net loss for the three-month fiscal period ended March 31, 2023, compared to $4.0 million of net earnings in the comparable fiscal period in the prior year. This decrease in net earnings was primarily driven by an increase in interest expense and lower non-service pension and post-retirement benefit income, partially offset by higher operating income and lower income tax expense. The resulting GAAP diluted loss per share was $(0.00) in the three-month fiscal period ending March 31, 2023, compared to earnings per share of $0.14 in the prior year period.

•Cash used in operating activities during the three-month fiscal period ended March 31, 2023, was $5.5 million, $4.4 million more than cash used in the comparable period in 2022. This change was largely driven by the timing of collection of payments in our Engineered Products segment and the timing of work performed on the JPF program, partially offset by lower incentive compensation payments and income tax refunds received in the current period.

•Total unfulfilled performance obligations ("backlog") increased 1.7% to $733.0 million compared to total backlog at December 31, 2022, driven by new orders in the Engineered Products segment, partially offset by revenue recognized for the period.

Recent events

•In March 2023, Kaman Corporation and PHI Aviation LLC (“PHI”) announced at the 2023 HAI Heli-Expo that Kaman’s subsidiary, Kaman Aerospace Corporation (“Kaman”) and PHI have entered into a master commercial agreement for the promotion, sales and support of a commercial version of Kaman’s KARGO UAV unmanned aerial

22

system, including collaboration relating to its ongoing design and certification. PHI also placed a 50 unit non-binding order for KARGO UAV unmanned aerial systems.

•In February 2023, Kaman Precision Products, Inc. ("KPPI"), and the Tawazun Council signed a Business Plan Approval Letter for Kaman EMEA, Inc. to establish a Height of Burst manufacturing and final assembly facility in collaboration with Remah International Group – Sole Proprietorship LLC at the Tawazun Industrial Park.

Impacts from Current Economy

We are currently operating in a period of global economic uncertainty, which has been significantly impacted by geopolitical instability due to the ongoing military conflict between Ukraine and Russia, continuing U.S. sanctions on China's microchip manufacturing, the coronavirus ("COVID-19") pandemic and inflation and rising interest rates. U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions, including the military conflict in Ukraine and the resulting sanctions imposed on Russia. Although the length and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine could lead to market disruptions, including significant volatility in credit and capital markets, increases in commodity prices, supply chain interruptions, as well as the potential for increased risk of cyber disruptions. We are continuing to monitor the situation in Ukraine, including its global effects, and assessing its potential impact on our business, including the timing of our sales as certain customers purchase safety stock for their own supply chains. Although our business has not been materially impacted by the ongoing military conflict in Ukraine as of the date of this filing, we have experienced higher utility costs at our Germany operations in light of the European Union’s sanctions on Russia. It is impossible to predict the extent to which our operations, or those of our customers or suppliers, will be impacted, or the ways in which the conflict may impact our business, cash flows or results of operations.

We also continue to monitor the impact of COVID-19 on all aspects of our business and across the geographies in which we operate and serve customers, as well as the extent to which it has impacted and may continue to impact our customers, suppliers and other business partners. We are operating below pre-pandemic levels for certain commercial aerospace products. We are encouraged by the recoveries for these products and the strong order intake we saw in the first three months of 2023.

The above forces have impacted our supply chain; we are seeing quality issues and defects, part shortages and increased lead times for certain parts. In addition to supply chain impacts, we have been and believe we will continue to be impacted by higher interest expense given our outstanding borrowings under our revolving credit facility with a floating interest rate. These impacts are likely to persist through 2023 and beyond. To mitigate risks associated with the floating interest rate on our credit facility, we entered into interest rate swap agreements, effective January 1, 2023, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These swaps will provide a fixed interest rate on approximately 70% of the Company's total long-term debt. We cannot predict the impact on the Company’s end markets or input costs nor the ability of the Company to recover cost increases through pricing.

RESULTS OF OPERATIONS

Refer to Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, of the Quarterly Report on Form 10-Q for the period ended April 1, 2022 for a discussion of changes for the earliest periods presented.

Net Sales

	For the Three Months Ended
	March 31, 2023			April 1, 2022
	(in thousands)
Net sales	$	194,542		$	158,048
$ change	36,494			(13,568)
% change	23.1		%	(7.9)		%
Acquisition sales	18,543			$	—
Organic sales	$	175,999		$	158,048
$ change	17,951
% change	11.4		%

23

Net sales for the three-month fiscal period ended March 31, 2023 increased when compared to the corresponding period in 2022, attributable to an 11.4% increase in organic sales and $18.5 million in sales from our Aircraft Wheel and Brake acquisition. The increase in organic sales was driven by $23.3 million in higher organic sales at the Engineered Products segment and a $4.2 million increase in sales at the Structures segment, partially offset by lower sales at our Precision Products segment. Foreign currency exchange rates relative to the U.S. dollar had an unfavorable impact of $1.3 million on net sales. See Segment Results of Operations and Financial Condition below for further discussion of segment net sales.

The table below summarizes the changes in organic net sales by product line for the three-month fiscal period ended March 31, 2023, compared to the corresponding period in 2022.

Product Line	Increase (Decrease)	$ (in millions)	%
Defense	↑	$5.9	18.9%
Safe and Arm Devices	↓	$(11.0)	(29.7)%
Commercial, Business and General Aviation	↑	$19.0	40.5%
Medical	↑	$3.7	16.2%
Industrial	↑	$0.4	2.1%

Gross Profit

	For the Three Months Ended
	March 31, 2023			April 1, 2022
	(in thousands)
Gross profit	$	67,544		$	50,587
$ change	16,957			(2,318)
% change	33.5		%	(4.4)		%
% of net sales	34.7		%	32.0		%

Gross profit increased for the three-month fiscal period ended March 31, 2023, as compared to the corresponding period in 2022. This increase was primarily attributable to the addition of gross profit associated with our Aircraft Wheel and Brake acquisition and higher sales and gross profit on our commercial and defense bearings products, springs, seals and contacts used in medical applications and our K-MAX® spares and support. These increases, totaling $21.5 million, were partially offset by lower sales and gross profit on our JPF program and cost growth on our AH-1Z program, Sikorsky UH-60 BLACK HAWK program and FireBurst program.

Gross profit as a percentage of sales increased for the three-month fiscal period ended March 31, 2023, as compared to the corresponding period in 2022. This increase was primarily attributable to the addition of gross profit associated with programs at Aircraft Wheel and Brake and improved performance on our K-MAX® spares and support and certain composite programs. These changes were partially offset by cost growth on certain legacy fuzing and structures programs.

Selling, General & Administrative Expenses (S,G&A)

	For the Three Months Ended
	March 31, 2023			April 1, 2022
	(in thousands)
S,G&A	$	43,698		$	39,721
$ change	3,977			1,593
% change	10.0		%	4.2		%
% of net sales	22.5		%	25.1		%

24

S,G&A increased for the three-month fiscal period ended March 31, 2023, when compared to the corresponding period in 2022. This was primarily attributable to the addition of S,G&A from Aircraft Wheel and Brake.

Restructuring and Severance Costs

	For the Three Months Ended
	March 31, 2023		April 1, 2022
	(in thousands)
Restructuring and severance costs	$	2,190	$	169

In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improve working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result of this review, the Company identified areas to reduce annualized costs in the Precision Products segment and at Corporate through streamlining processes, consolidating the production of fuzes for the JPF program at its Middletown facility, discontinuing K-MAX® helicopter production and right-sizing the Company's total cost structure. In connection with these restructuring actions, the Company currently expects to incur approximately $10.0 to $12.0 million in total pre-tax restructuring charges, consisting of approximately $9.0 to $10.0 million of cash expenditures relating to various headcount reduction and personnel initiatives and approximately $1.0 to $2.0 million of cash expenditures relating to facility closing costs, which we anticipate will generate approximately $25.0 million in total annualized costs savings by 2024. In the three-month fiscal period ended March 31, 2023, the Company incurred $2.2 million in severance costs associated with these actions. Since the announcement of these actions, we have incurred $8.8 million in costs through March 31, 2023.

Operating Income

	For the Three Months Ended
	March 31, 2023			April 1, 2022
	(in thousands)
Operating income	$	8,628		$	3,057
$ change	5,571			(2,556)
% change	182.2		%	(45.5)		%
% of net sales	4.4		%	1.9		%

Operating income increased for the three-month fiscal period ended March 31, 2023, as compared to the corresponding period in 2022. This increase was primarily driven by higher operating income at the Engineered Products segment, partially offset by lower operating income at the Precision Products segment. See Segment Results of Operations and Financial Condition below for further discussion of segment operating income.

Interest Expense, Net

	For the Three Months Ended
	March 31, 2023		April 1, 2022
	(in thousands)
Interest expense, net	$	9,604	$	2,481

Interest expense, net, generally consists of interest charged on our Credit Agreement, which includes a revolving credit facility, our convertible notes and the amortization of debt issuance costs, offset by interest income. Interest expense, net for the three-month fiscal period ended March 31, 2023 increased when compared to the corresponding period in 2022, primarily due to a $5.9 million increase in interest expense on our revolving credit agreement as a result of higher borrowings and higher interest expense associated with our deferred compensation plan.

25

Effective Income Tax Rate

	For the Three Months Ended
	March 31, 2023		April 1, 2022
Effective income tax rate	20.8	%	24.5	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings for the period. The decrease in the effective tax rate for the three-month period ended March 31, 2023 as compared to the corresponding rate in the prior year period was primarily driven by lower net earnings in the current period.

SEGMENT RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Engineered Products Segment

Results of Operations

	For the Three Months Ended
	March 31, 2023			April 1, 2022
	(in thousands)
Net sales	$	123,326		$	81,452
$ change	41,874			9,673
% change	51.4		%	13.5		%
Operating income	$	19,356		$	11,042
$ change	8,314			6,136
% change	75.3		%	125.1		%
% of net sales	15.7		%	13.6		%

Net Sales

Net sales for the three-month fiscal period ended March 31, 2023 increased compared to the corresponding period in 2022, driven by higher sales volume of our commercial and defense bearings products, aftermarket parts and springs, seals and contacts used in medical applications, as well as $18.5 million in revenue from our newly-acquired Aircraft Wheel and Brake division. For the three-month fiscal period ended March 31, 2023, foreign currency exchange rates relative to the U.S. dollar had an unfavorable impact of $1.3 million on net sales.

Operating Income

Operating income for the three-month fiscal period ended March 31, 2023 increased when compared to the corresponding period in 2022, primarily due to the contribution of gross profit from our Aircraft Wheel and Brake acquisition and higher sales and associated gross profit on our commercial and defense bearings products and seals, springs and contacts used in medical applications. These increases in gross profit, totaling $18.9 million, were partially offset by the addition of S,G&A and $4.8 million in intangible asset amortization from Aircraft Wheel and Brake. Foreign currency exchange rates relative to the U.S. dollar had an unfavorable impact of $0.6 million on operating income.

26

Precision Products Segment

Results of Operations

	For the Three Months Ended
	March 31, 2023			April 1, 2022
	(in thousands)
Net sales	$	37,971		$	47,549
$ change	(9,578)			(12,984)
% change	(20.1)		%	(21.4)		%
Operating income	$	1,674		$	3,409
$ change	(1,735)			(9,644)
% change	(50.9)		%	(73.9)		%
% of net sales	4.4		%	7.2		%

Net Sales

Net sales for the three-month fiscal period ended March 31, 2023 decreased when compared to the corresponding period in 2022, primarily due to lower sales on the JPF program and our measuring programs. These decreases, totaling $12.6 million, were partially offset by higher sales on our K-MAX® spares and support and the JASSM® fuzing program.

Operating Income

Operating income for the three-month fiscal period ended March 31, 2023 decreased when compared to the corresponding period in 2022, primarily attributable to lower sales and gross profit on the JPF program, cost growth on the ATACMS program and the FireBurst program, and higher research and development costs for the KARGO UAV unmanned aerial system. These changes, totaling $5.0 million, were partially offset by higher gross profit on our K-MAX® spares and support and the JASSM® fuzing program.

Major Programs/Product Lines

Below is a discussion of significant changes in major programs within the Precision Products segment during the first three months of 2023. See our 2022 Form 10-K, including Item 1A, "Risk Factors", for a complete discussion of our major programs.

FMU-152 A/B – JPF

We manufacture and produce the FMU 152 A/B (the "JPF"), an electro-mechanical bomb safe and arming device, which allows the settings of a weapon to be programmed in flight. Sales of these fuzes can be direct to the U.S. Government ("USG"), Foreign Military Sales ("FMS") through the USG and Direct Commercial Sales (“DCS”) to foreign militaries that, although not funded by or sold through the USG, require regulatory approvals from the USG.

A total of 6,704 fuzes were delivered to our customers during the first quarter of 2023. We expect to deliver 9,000 to 12,000 fuzes in 2023. Total JPF backlog at March 31, 2023 was $4.8 million, down from $20.0 million at December 31, 2022. We expect to recognize the majority of this backlog within the first half of 2023.

Our JPF program continues to wind down as it moves to the end of its lifecycle, reflecting the previously announced decision of the United States Air Force ("USAF") to move from the JPF to the FMU-139 D/B (which we do not manufacture or produce) as its primary fuze system. We expect to complete Option 16 of our JPF contract with the USG in the first half of 2023, which relates solely to the procurement of fuzes by or in support of foreign militaries and does not include any sales to the USAF. The USG has indicated that they will not award us any future options; therefore, the future viability of our JPF program will depend entirely on our ability to market and sell the JPF to foreign militaries in DCS transactions. We are currently in discussions with two Middle Eastern customers for one or more follow-on orders aggregating a minimum of $45.0 million that would further extend the life of the program, but there can be no assurance as to the receipt, magnitude and timing of these orders. Moreover, any such orders, if received, would be subject to the receipt of all necessary export approvals, licenses and other authorizations needed to effectuate the sales, which are subject to political and geopolitical conditions beyond our control.

27

In the fourth quarter of 2022, we announced a restructuring plan that will lead to the permanent closure of our Orlando, Florida manufacturing facility by the end of 2024. The Company has begun to consolidate JPF production in its Middletown, Connecticut, facility as the facility has the potential capacity to deliver against future DCS orders.

Structures Segment

Results of Operations

	For the Three Months Ended
	March 31, 2023			April 1, 2022
	(in thousands)
Net sales	$	33,245		$	29,047
$ change	4,198			(10,257)
% change	14.5		%	(26.1)		%
Operating loss	$	(237)		$	(617)
$ change	(380)			(937)
% change	(61.6)		%	(292.8)		%
% of net sales	(0.7)		%	(2.1)		%

Net Sales

Net sales for the three-month fiscal period ended March 31, 2023 increased when compared to the corresponding period in 2022, primarily due to higher sales on our programs with Rolls Royce, certain Sikorsky programs and composites programs. These increases, totaling $7.4 million, were partially offset by the wind down of the AH-1Z program and lower sales on our Sikorsky UH-60 BLACK HAWK program.

Operating Loss

The Structures segment incurred a lower operating loss for the three-month fiscal period ended March 31, 2023 when compared to the corresponding period in 2022, primarily driven by higher sales and gross profit on our programs with Rolls Royce and certain composites programs. These increases in gross profit, totaling $1.0 million, were partially offset by lower sales and gross profit on the UH-60 Sikorsky BLACK HAWK program and lower gross profit on the Sikorsky Combat Rescue Helicopter.

Backlog

	March 31, 2023		December 31, 2022
	(in thousands)
Engineered Products	$	369,713	$	322,452
Precision Products	111,750		134,903
Structures	251,531		263,581
Total Backlog	$	732,994	$	720,936

The increase in backlog during the first three months of 2023 was primarily attributable to new orders for our bearings products, our seals, springs and contacts, and our aircraft wheels and brakes and under our programs with Rolls Royce. These increases were partially offset by revenue recognized in the period.

LIQUIDITY AND CAPITAL RESOURCES

Discussion and Analysis of Cash Flows

We assess liquidity in terms of our ability to generate cash to fund working capital requirements and investing and financing activities. Significant factors affecting liquidity include: cash flows generated from or used by operating activities, capital

28

expenditures, investments in our business and programs, acquisitions, divestitures, dividends, availability of future credit, share repurchase programs, adequacy of available bank lines of credit, and factors that might otherwise affect the Company's business and operations generally, as described under the heading “Risk Factors” and “Forward-Looking Statements” in Item 1A of Part I of our 2022 Form 10-K.

A summary of our consolidated cash flows is as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022		2023 vs. 2022
	(in thousands)
Total cash provided by (used in):
Operating activities	$	(5,453)	$	(1,017)	$	(4,436)
Investing activities	(8,798)		(6,453)		(2,345)
Financing activities	43,970		(4,035)		48,005
Free Cash Flow (a)
Net cash used in operating activities	$	(5,453)	$	(1,017)	$	(4,436)
Expenditures for property, plant and equipment	(5,948)		(6,877)		929
Free cash flow	$	(11,401)	$	(7,894)	$	(3,507)

(a) Free Cash Flow, a non-GAAP financial measure, is defined as net cash (used in) provided by operating activities less expenditures for property, plant and equipment, both of which are presented in our Condensed Consolidated Statements of Cash Flows. See Management’s Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Measures for more information regarding Free Cash Flow.

Net cash used in operating activities was $5.5 million for the three-month fiscal period ended March 31, 2023, $4.4 million more than cash used in the comparable period in 2022. This change was largely driven by the timing of collection of payments in our Engineered Products segment and the timing of work performed on the JPF program, partially offset by lower incentive compensation payments and the receipt of approximately $10.0 million in income tax refunds in the current period.

Net cash used in investing activities was $8.8 million for the three-month fiscal period ended March 31, 2023, $2.3 million more than cash used in the comparable period in 2022. This increase was primarily attributable to the settlement of the working capital adjustment associated with the acquisition of Aircraft Wheel and Brake. Refer to Note 2, Business Combinations and Investments, for further information on this acquisition.

Net cash provided by financing activities was $44.0 million for the three-month fiscal period ended March 31, 2023, compared to net cash used of $4.0 million in the comparable period in 2022. This change was primarily due to borrowings under our Credit Agreement in the current period.

We anticipate a variety of items will have an impact on our liquidity during the next twelve months, in addition to our working capital requirements. These could include one or more of the following:

•the matters described in Note 12, Commitments and Contingencies, in the Notes to Condensed Consolidated Financial Statements, including the cost of existing environmental remediation matters;

•contributions to our qualified pension plan and Supplemental Employees’ Retirement Plan (“SERP”);

•deferred compensation payments to officers;

•interest payments on outstanding debt;

•income tax payments;

•costs associated with acquisitions and corporate development activities;

•finance and operating lease payments;

•capital expenditures;

•research and development expenditures;

•repurchase of common stock under share repurchase programs;

•payment of dividends;

•costs associated with the start-up of new programs; and

•the timing of payments and the extension of payment terms by our customers.

29

Financing Arrangements

We continue to rely upon bank financing as an important source of liquidity for our business activities, including acquisitions. We believe this, when combined with cash generated from operating activities, will be sufficient to support our anticipated future cash requirements; however, we may decide to borrow additional funds or raise additional equity capital to support other business activities, including potential future acquisitions. We regularly monitor credit market conditions to identify potential issues that may adversely affect, or provide opportunities for, the securing and/or advantageous pricing of additional financing, if any, that may be necessary to continue with our growth strategy and finance working capital requirements. Our long-term debt instruments will mature in 2024, as discussed below. We are currently assessing potential options for the refinancing of these instruments prior to their scheduled maturity. Refer to Note 14, Debt, in the Notes to the Consolidated Financial Statements, included in Item 8, Financial Statements and Supplementary Data, of the 2022 Form 10-K for further information on our Financing Arrangements.

Convertible Notes

During May 2017, we issued $200.0 million aggregate principal amount of convertible senior unsecured notes due May 2024 (the "2024 Notes") pursuant to an indenture, dated May 12, 2017, between the Company and U.S. Bank National Association, as trustee (as amended by the First Supplemental Indenture thereto, dated July 15, 2019, the "Indenture"). In connection therewith, we entered into certain capped call transactions that cover, collectively, the number of shares of the Company's common stock underlying the 2024 Notes. The 2024 Notes bear 3.25% interest per annum on the principal amount, payable semiannually in arrears on May 1 and November 1 of each year, beginning on November 1, 2017. The 2024 Notes will mature on May 1, 2024, unless earlier repurchased by the Company or converted. We will settle any conversions of the 2024 Notes in cash, shares of the Company's common stock or a combination of cash and shares of common stock, at our election.

The sale of our former Distribution business in the third quarter of 2019 was deemed to be a "Fundamental Change" and a "Make-Whole Fundamental Change" pursuant to the terms and conditions of the indenture governing the 2024 Notes. As a result, the sale triggered the right of the holders of our 2024 Notes to require us to repurchase all of the 2024 Notes, or any portion thereof that is a multiple of $1,000 principal amount on September 27, 2019. The aggregate principal amount of the 2024 Notes validly tendered and not validly withdrawn was $0.5 million, representing approximately 0.25% of all outstanding notes. Holders of such notes received the repurchase price equal to 100% of the principal amount of the 2024 Notes being purchased, plus accrued and unpaid interest.

We incurred $7.4 million of debt issuance costs in connection with the sale of the 2024 Notes, which were allocated between the debt and equity components of the instrument at issuance. Of the total amount, $0.7 million was recorded as an offset to additional paid-in capital. The balance, $6.7 million, was recorded as a contra-debt balance and was being amortized over the term of the 2024 Notes. As a result of the adoption of ASU 2020-06, the amount recorded to additional paid-in capital was reclassified to retained earnings in the cumulative effect adjustment recorded on January 1, 2022. The remaining balance of debt issuance costs is being amortized over the term of the convertible notes. Total amortization expense for the three-month fiscal periods ended March 31, 2023 and April 1, 2022 was $0.3 million and $0.2 million, respectively.

Credit Agreement

On December 13, 2019, the Company closed an amended and restated $800.0 million Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A., as Administrative Agent and as Collateral Agent. The Credit Agreement matures on December 13, 2024 and consists of revolving commitments of $800.0 million. Capitalized terms used but not defined within this discussion of the Credit Agreement have the meanings ascribed thereto in the Credit Agreement, which with amendments is included as Exhibit 10.42 to our 2022 Form 10-K.

At March 31, 2023, $411.0 million was outstanding under the revolving credit facility. Interest rates on amounts outstanding under the Credit Agreement are variable based on the Secured Overnight Financing Rate ("SOFR"). The interest rate at March 31, 2023 was 6.17%. We are required to pay a quarterly commitment fee on the unused revolving loan commitment amount at a rate ranging from 0.150% to 0.250% per annum, based on the Senior Secured Net Leverage Ratio. Fees for outstanding letters of credit range from 1.125% to 1.625%, based on the Senior Secured Net Leverage Ratio. Total average bank borrowings were $383.8 million during the three-month fiscal period ended March 31, 2023. Total average bank borrowings were $120.7 million during the year ended December 31, 2022. As of March 31, 2023, the Consolidated Total Net Leverage Ratio was 3.78, as calculated in accordance with the Credit Agreement, as compared to the ceiling of 5.00 to 1.00.

30

The following table shows the amounts available for borrowing under the Company's revolving credit facility:

	March 31, 2023		December 31, 2022
In thousands
Total facility	$	800,000	$	800,000
Amounts outstanding, excluding letters of credit	411,000		363,000
Amounts available for borrowing, excluding letters of credit	389,000		437,000
Letters of credit under the credit facility(1)(2)	51,480		51,630
Amounts available for borrowing	$	337,520	$	385,370
Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement	$	193,037	$	211,131

(1) The Company has entered into standby letters of credit issued on the Company's behalf by financial institutions, and directly issued guarantees to third parties primarily related to advances received from customers and the guarantee of future performance on certain contracts. Letters of credit generally are available for draw down in the event the Company does not perform its obligations.

(2) Of these amounts, $46.1 million letters of credit relate to a JPF DCS contract in both periods ended March 31, 2023 and December 31, 2022.

Debt issuance costs in connection with the Credit Agreement have been capitalized and are being amortized over the term of the agreement. In 2019, we incurred $3.6 million of debt issuance costs in connection with the amendment and restatement of the Credit Agreement. We incurred an additional $4.4 million of debt issuance costs in connection with the amendment of the Credit Agreement in 2022. Total amortization expense for the three-month fiscal periods ended March 31, 2023 and April 1, 2022 was $0.6 million and $0.2 million, respectively.

Interest Rate Swaps

During 2022, we entered into interest rate swap agreements, effective January 1, 2023, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These interest rate swap agreements were designated as cash flow hedges and intended to manage interest rate risk associated with our variable-rate borrowings and minimize the impact on our earnings and cash flows of interest rate fluctuations attributable to changes in SOFR. These interest rate swaps were not material to the Company's Condensed Consolidated Financial Statements as of March 31, 2023. Over the next twelve months, the income related to cash flow hedges expected to be reclassified from other comprehensive income is $0.3 million.

Other Sources/Uses of Capital

Letters of Credit

Of the standby letters of credit under our credit facility, $46.1 million in letters of credit relate to a JPF DCS contract, including the offset agreement. In the event that we default on the contract and we are unable to fulfill our contractual obligations, our customer has the ability to draw on the letters of credit.

Pension Plans

Management regularly monitors pension plan asset performance and the assumptions used in the determination of our benefit obligation, comparing them to actual performance. We continue to believe the assumptions selected are valid due to the long-term nature of our benefit obligation.

No contributions are expected to be made to the qualified pension plan during 2023. The Company contributed $0.1 million to the SERP through the end of the first quarter of 2023 and plans to contribute an additional $0.4 million to the SERP in 2023. No contribution was made to the qualified pension plan and we paid $0.5 million in SERP benefits in 2022.

Share-based Arrangements

As of March 31, 2023, future compensation costs related to non-vested stock options, restricted stock grants and performance stock grants is $13.6 million. The Company anticipates that this cost will be recognized over a weighted-average period of 2.3 years.

31

NON-GAAP FINANCIAL MEASURES

Management believes the non-GAAP (Generally Accepted Accounting Principles) measures used in this report provide investors with important perspectives into our ongoing business performance. We do not intend for the information to be considered in isolation or as a substitute for the related GAAP measures. Other companies may define the measures differently. We define the non-GAAP measures used in this report and other disclosures as follows:

Organic Sales

Organic Sales is defined as "Net Sales" less sales derived from acquisitions completed during the previous twelve months. We believe that this measure provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, which can obscure underlying trends. We also believe that presenting Organic Sales separately provides management and investors with useful information about the trends impacting our operations and enables a more direct comparison to other businesses and companies in similar industries. Management recognizes that the term "Organic Sales" may be interpreted differently by other companies and under different circumstances.

Organic Sales (in thousands)
	For the Three Months Ended
	March 31, 2023		April 1, 2022
Net sales	$	194,542	$	158,048
Acquisition sales	18,543		—
Organic Sales	$	175,999	$	158,048

Free Cash Flow

Free Cash Flow is defined as GAAP “Net cash provided by (used in) operating activities” in a period less “Expenditures for property, plant & equipment” in the same period. Management believes Free Cash Flow provides an important perspective on our ability to generate cash from our business operations and, as such, that it is an important financial measure for use in evaluating the Company's financial performance. Free Cash Flow should not be viewed as representing the residual cash flow available for discretionary expenditures such as dividends to shareholders or acquisitions, as it may exclude certain mandatory expenditures such as repayment of maturing debt and other contractual obligations. Management uses Free Cash Flow internally to assess overall liquidity.

CONTRACTUAL OBLIGATIONS AND OFF-BALANCE SHEET ARRANGEMENTS

There have been no material changes outside the ordinary course of business in our contractual obligations or off-balance sheet arrangements during the first three months of 2023. See our 2022 Form 10-K for a discussion of our contractual obligations and off-balance sheet arrangements.

CRITICAL ACCOUNTING ESTIMATES

Preparation of the Company’s financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Management believes the most complex and sensitive judgments, because of their significance to the Consolidated Financial Statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain. Management’s Discussion and Analysis and the Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K describe the critical accounting estimates and significant accounting policies used in preparing the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates.

RECENT ACCOUNTING STANDARDS

There have been no recent changes in accounting standards during the first three months of 2023.

32

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in the Company’s exposure to market risk during the first three months of 2023. See the Company’s 2022 Form 10-K for a discussion of the Company’s exposure to market risk.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We have carried out an evaluation, under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Act of 1934, as amended, as of March 31, 2023. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon our evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2023, our disclosure controls and procedures were effective.

Internal Controls over Financial Reporting

There was no change to our internal control over financial reporting that occurred during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to affect, our internal control over financial reporting.

33

PART II

Item 1. Legal Proceedings

General

From time to time, as a normal incident of the nature and kinds of businesses in which the Company and its subsidiaries are, and were, engaged, various claims or charges are asserted and legal proceedings are commenced by or against the Company and/or one or more of its subsidiaries. Claimed amounts may be substantial but may not bear any reasonable relationship to the merits of the claim or the extent of any real risk of court or arbitral awards. We record accruals for losses related to those matters that we consider to be probable and that can be reasonably estimated. Gain contingencies, if any, are recognized when they are realized and legal costs generally are expensed when incurred.

We evaluate, on a quarterly basis, developments in legal proceedings that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. Our loss contingencies are subject to substantial uncertainties, however, including for each such contingency the following, among other factors: (i) the procedural status of the case; (ii) whether the case has or may be certified as a class action suit; (iii) the outcome of preliminary motions; (iv) the impact of discovery; (v) whether there are significant factual issues to be determined or resolved; (vi) whether the proceedings involve a large number of parties and/or claims in multiple jurisdictions or jurisdictions in which the relevant laws are complex or unclear; (vii) the extent of potential damages, which are often unspecified or indeterminate; and (viii) the status of settlement discussions, if any, and the settlement postures of the parties. Because of these uncertainties, management has determined that, except as otherwise noted below, the amount of loss or range of loss that is reasonably possible in respect of each matter described below (including any reasonably possible losses in excess of amounts already accrued), is not reasonably estimable.

While it is not possible to predict the outcome of these matters with certainty, based upon available information, management believes that all settlements, arbitration awards and final judgments, if any, which are considered probable of being rendered against us in legal proceedings and that can be reasonably estimated are accrued for at March 31, 2023. Despite this analysis, there can be no assurance that the final outcome of these matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows.

As of March 31, 2023, neither the Company nor any of its subsidiaries was a party, nor was any of its or their property subject, to any material pending legal proceedings, other than ordinary routine litigation incidental to the business of the Company and its subsidiaries. Additional information relating to certain of these matters is set forth in Note 12, Commitments and Contingencies, of the Notes to Condensed Consolidated Financial Statements.

Aircraft Safety Matters

The Company designs, manufactures, services and sells complex and sophisticated aerospace parts, subassemblies and aircraft. These products are manufactured according to detailed specifications and are subject to strict approval or certification requirements. Technical, mechanical and other failures may occur as a result of manufacturing or design defects, operational processes or production issues attributable to us, our customers, suppliers, third party integrators or others. Due to the nature of the Company's business, liability claims may arise from accidents involving products the Company has manufactured, including claims for injury or death. Product or system failures could result in product recalls, regulatory directives and product liability and warranty claims (including claims related to the safety or reliability of our products). Such failures could also lead to service, repair and maintenance costs, damages and fines and regulatory and environmental liabilities. While management believes that the Company maintains adequate insurance for these risks, insurance cannot be obtained to protect against all risks and liabilities. It is therefore possible that the insurance coverage may not cover all claims or liabilities, and the Company may be forced to bear unanticipated costs or liabilities. As of March 31, 2023, the Company is party to pending litigation relating to an incident involving a K-MAX® helicopter that resulted in a fatality, and the Company has been notified of potential claims relating to another such incident. Each incident is the subject of one or more investigations undertaken by applicable civil aviation agencies located in the jurisdiction of the incident. While it is not possible to predict the outcome of any investigations, litigation or claims relating to these or other potential incidents, management believes that all such investigations, litigation or claims in existence at March 31, 2023, are not reasonably likely to have a material adverse effect on our business, financial condition and results of operations or cash flows.

34

Environmental Matters

The Company and its subsidiaries are subject to numerous U.S. federal, state and international environmental laws and regulatory requirements and are involved from time to time in investigations or litigation of various potential environmental issues concerning activities at our facilities or former facilities or remediation as a result of past activities (including past activities of companies we have acquired). From time to time, we receive notices from the U.S. Environmental Protection Agency or equivalent state or international environmental agencies that we are a potentially responsible party under the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as the “Superfund Act”) and/or equivalent laws. Such notices assert potential liability for cleanup costs at various sites, which may include sites owned by us, sites we previously owned and treatment or disposal sites not owned by us, allegedly containing hazardous substances attributable to us from past operations. While it is not possible to predict the outcome of these proceedings, in the opinion of management, any payments we may be required to make as a result of all such claims in existence at March 31, 2023, will not have a material adverse effect on our business, financial condition and results of operations or cash flows.

Item 1A. Risk Factors

Investors should carefully review and consider the information regarding certain factors that could materially affect our business, results of operations, financial condition and cash flows as set forth under Item 1A. “Risk Factors” in our 2022 Form 10-K. Except as set forth below, we do not believe there have been any material changes to the risk factors previously disclosed in our 2022 Form 10-K, but we may disclose changes to such factors or disclose additional factors from time to time in future filings with the SEC. Additional risks and uncertainties not presently known to us or that we currently believe not to be material may also adversely impact our business, results of operations, financial position and cash flows.

We design, manufacture, service and sell complex aerospace parts, subassemblies and aircraft that subject us to potential risks and liabilities in the event they do not operate as intended.

The Company designs, manufactures, services and sells complex and sophisticated aerospace parts, subassemblies and aircraft. These products are manufactured according to detailed specifications and are subject to strict approval or certification requirements. Technical, mechanical and other failures have occurred in the past, and may occur in the future, whether as a result of manufacturing or design defects, operational processes or production issues attributable to us, our customers, suppliers, third party integrators or others. Our products could also fail as a result of cyber-attacks, such as those that seize control and result in misuse or unintended use of our products, or other intentional acts. Due to the nature of the Company's business, liability claims have arisen, and may arise in the future, from accidents or disasters involving products the Company has manufactured, including claims for injury or death. Product or system failures could result in negative publicity that could reduce demand for our products, product recalls, regulatory directives and product liability and warranty claims (including claims related to the safety or reliability of our products). Such failures could also lead to service, repair and maintenance costs, damages and fines and regulatory and environmental liabilities. While management believes that the Company maintains adequate insurance for these risks, insurance cannot be obtained to protect against all risks and liabilities. It is therefore possible that the insurance coverage may not cover all claims or liabilities, and the Company may be forced to bear unanticipated costs or liabilities. As of March 31, 2023, the Company is party to pending litigation relating to an incident involving a K-MAX® helicopter that resulted in a fatality, and the Company has been notified of potential claims relating to another such incident. Each incident is the subject of one or more investigations undertaken by applicable civil aviation agencies located in the jurisdiction of the incident. While it is not possible to predict the outcome of any investigations, litigation or claims relating to these or other potential incidents, management believes that all such investigations, litigation or claims in existence at March 31, 2023, are not reasonably likely to have a material adverse effect on our business, financial condition and results of operations or cash flows.

FORWARD-LOOKING STATEMENTS

This report contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

35

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others: (i) changes in domestic and foreign economic and competitive conditions in markets served by the Company, particularly the defense, commercial aviation and industrial production markets; (ii) changes in government and customer priorities and requirements (including cost-cutting initiatives, government and customer shut-downs, the potential deferral of awards, terminations or reductions of expenditures to respond to the priorities of Congress and the Administration, or budgetary cuts resulting from Congressional actions or automatic sequestration); (iii) the global economic impact of the COVID-19 pandemic; (iv) risks and uncertainties associated with the successful integration of our Aircraft Wheel and Brake acquisition; (v) changes in geopolitical conditions in countries where the Company does or intends to do business; (vi) the successful conclusion of competitions for government programs (including new, follow-on and successor programs) and thereafter successful contract negotiations with government authorities (both foreign and domestic) for the terms and conditions of the programs; (vii) the timely receipt of any necessary export approvals and/or other licenses or authorizations from the USG; (viii) timely satisfaction or fulfillment of material contractual conditions precedents in customer purchase orders, contracts, or similar arrangements; (ix) the existence of standard government contract provisions permitting renegotiation of terms and termination for the convenience of the government; (x) the successful resolution of government inquiries or investigations relating to our businesses and programs; (xi) risks and uncertainties associated with the successful implementation and ramp up of significant new programs, including the ability to manufacture the products to the detailed specifications required and recover start-up costs and other investments in the programs; (xii) potential difficulties associated with variable acceptance test results, given sensitive production materials and extreme test parameters; (xiii) the receipt and successful execution of production orders under the Company's existing USG JPF contract, including the exercise of all contract options and receipt of orders from allied militaries, but excluding any next generation programmable fuze programs, as all have been assumed in connection with goodwill impairment evaluations; (xiv) the continued support of the existing K-MAX® helicopter fleet, including sale of existing K-MAX® spare parts inventory and the receipt of orders for new aircraft sufficient to recover our investments in the K-MAX® production line; (xv) the accuracy of current cost estimates associated with environmental remediation activities; (xvi) the profitable integration of acquired businesses into the Company's operations; (xvii) the ability to recover from cyber-based or other security attacks, information technology failures or other disruptions; (xviii) changes in supplier sales or vendor incentive policies; (xix) the ability of our suppliers to satisfy their performance obligations, including any supply chain disruptions; (xx) the effects of price increases or decreases; (xxi) the effects of pension regulations, pension plan assumptions, pension plan asset performance, future contributions and the pension freeze; (xxii) future levels of indebtedness and capital expenditures; (xxiii) compliance with our debt covenants; (xxiv) the continued availability of raw materials and other commodities in adequate supplies and the effect of increased costs for such items; (xxv) the effects of currency exchange rates and foreign competition on future operations; (xxvi) changes in laws and regulations, taxes, interest rates, inflation rates and general business conditions; (xxvii) future repurchases and/or issuances of common stock;(xxviii) the occurrence of unanticipated restructuring costs or the failure to realize anticipated savings or benefits from past or future expense reduction actions; (xxix) the ability to recruit and retain skilled employees; (xxx) the successful resolution of all pending and future investigations, litigation or claims relating to the manufacture or design of our products, including, without limitation, the K-MAX® helicopter; and (xxxi) other risks and uncertainties set forth herein and in our 2022 Form 10-K.

Any forward-looking information provided in this report should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

36

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about purchases of common stock by the Company during the three-month fiscal period ended March 31, 2023:

Period	Total Number of Shares Purchased (a)	Average Price Paid per Share		Total Number of Shares Purchased as Part of a Publicly Announced Plan (b)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plan(b) (in thousands)
January 1, 2023 - January 27, 2023	6,294	$	23.37	—	$50,000
January 28, 2023 - February 24, 2023	4,366	$	25.23	—	$50,000
February 25, 2023 - March 31, 2023	9,467	$	26.00	—	$50,000
Total	20,127			—

(a) During the first quarter of 2023, the Company purchased 20,127 shares in connection with employee tax withholding obligations as permitted by our equity compensation plans, which are SEC Rule 16b-3 qualified compensation plans. These were not purchases under our publicly announced program.

(b) On April 20, 2022, the Company announced that its Board of Directors approved a $50.0 million share repurchase program. This plan replaces the authorization approved in April 2015. For additional information, see "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations -- Liquidity and Capital Resources -- Other Sources/Uses of Capital" in this Form 10-Q for the three-month fiscal period ended March 31, 2023.

37

Item 6.     Index To Exhibits

10.1	Kaman Corporation Second Amended and Restated 2013 Management Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated April 21, 2023, File No. 001-35419).*	Previously Filed
10.2	Form of Non-Employee Director Equity Award Agreement (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated April 21, 2023, File No. 001-35419).*	Previously Filed
10.3	Form of Restricted Share Agreement under the Amended and Restated Kaman Corporation 2013 Management Incentive Plan, for awards granted on or after February 21, 2023 (incorporated by reference to Exhibit 10.8 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, File No. 001-35419).*	Previously Filed
10.4	Separation and Release Agreement, dated January 17, 2023, by and between the Company and Russell J. Bartlett (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated January 18, 2023, File No. 001-35419).*	Previously Filed
10.5	Separation and Release Agreement, dated January 17, 2023, by and between the Company and Shawn G. Lisle (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated January 18, 2023, File No. 001-35419).*	Previously Filed
10.6	Separation and Release Agreement, dated January 17, 2023, by and between the Company and Rafael Z. Cohen (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated January 18, 2023, File No. 001-35419).*	Previously Filed
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14 under the Securities Exchange Act of 1934	Filed Herewith
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14 under the Securities Exchange Act of 1934	Filed Herewith
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Furnished Herewith
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Furnished Herewith
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101

* Management contract or compensatory plan.

38

SIGNATURES

Kaman Corporation and Subsidiaries

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		KAMAN CORPORATION
		Registrant
Date:	May 2, 2023		/s/ Ian K. Walsh
		By:	Ian K. Walsh
			Chairman, President and
			Chief Executive Officer

Date:	May 2, 2023		/s/ James G. Coogan
		By:	James G. Coogan
			Senior Vice President,
			Chief Financial Officer and Treasurer

39

EX-31.1

Exhibit 31.1

Certification Pursuant to Rule

13a-14 under the Securities

Exchange Act of 1934

I, Ian K. Walsh, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Kaman Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 2, 2023	By:	/s/ Ian K. Walsh
			Ian K. Walsh
			Chairman, President and
			Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification Pursuant to Rule

13a-14 under the Securities and

Exchange Act of 1934

I, James G. Coogan, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Kaman Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 2, 2023	By:	/s/ James G. Coogan
			James G. Coogan
			Senior Vice President,
			Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

Certification Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Kaman Corporation (the "Corporation") on Form 10-Q for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ian K. Walsh, Chairman, President and Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

By:	/s/ Ian K. Walsh
	Ian K. Walsh
	Chairman, President and
	Chief Executive Officer
	May 2, 2023

EX-32.2

Exhibit 32.2

Certification Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Kaman Corporation (the "Corporation") on Form 10-Q for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, James G. Coogan, Senior Vice President and Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

By:	/s/ James G. Coogan
	James G. Coogan
	Senior Vice President,
	Chief Financial Officer and Treasurer
	May 2, 2023

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2023	Apr. 28, 2023
Document and Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-35419
Entity Registrant Name	KAMAN CORPORATION
Entity Incorporation, State or Country Code	CT
Entity Tax Identification Number	06-0613548
Entity Address, Address Line One	1332 Blue Hills Avenue,
Entity Address, City or Town	Bloomfield,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06002
City Area Code	(860)
Local Phone Number	243-7100
Title of 12(b) Security	Common Stock ($1 par value)
Trading Symbol	KAMN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		28,175,986
Entity Central Index Key	0000054381
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 53,986	$ 24,154
Accounts receivable, net	101,292	87,659
Contract assets	116,168	113,182
Inventories	186,495	176,468
Income tax refunds receivable	1,321	13,981
Other current assets	22,975	16,114
Total current assets	482,237	431,558
Property, plant and equipment, net of accumulated depreciation of $274,458 and $268,089, respectively	203,266	201,606
Operating Lease, Right-of-Use Asset	6,618	7,391
Goodwill	382,504	379,854
Other intangible assets, net	365,427	372,331
Deferred income taxes	47,818	47,385
Other assets	50,788	51,207
Total assets	1,538,658	1,491,332
Current liabilities:
Accounts payable – trade	47,194	48,277
Accrued salaries and wages	26,258	31,395
Contract liabilities, current portion	6,044	4,081
Operating Lease, Liability, Current	3,121	3,332
Income taxes payable	170	393
Other current liabilities	44,210	39,097
Total current liabilities	126,997	126,575
Long-term debt, excluding current portion, net of debt issuance costs	609,325	561,061
Deferred income taxes	6,365	6,079
Underfunded pension	51,459	52,309
Contract liabilities, noncurrent portion	20,329	20,515
Operating Lease, Liability, Noncurrent	3,905	4,534
Other Liabilities, Noncurrent	36,322	36,280
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock, $1 par value, 200,000 shares authorized; none outstanding	0	0
Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,766,419 and 30,640,068 shares issued, respectively	30,766	30,640
Additional paid-in capital	247,812	245,436
Retained earnings	682,812	688,457
Accumulated other comprehensive income (loss)	$ (154,793)	$ (158,421)
Treasury Stock, Common, Shares	2,632,334	2,607,841
Less 2,632,334 and 2,607,841 shares of common stock, respectively, held in treasury, at cost	$ (122,641)	$ (122,133)
Total shareholders’ equity	683,956	683,979
Total liabilities and shareholders’ equity	$ 1,538,658	$ 1,491,332

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Income Statement [Abstract]
Net sales	$ 194,542	$ 158,048
Cost of sales	126,998	107,461
Gross profit	67,544	50,587
Selling, general and administrative expenses	43,698	39,721
Research and Development Expense	5,907	5,113
Amortization of Intangible Assets	7,152	2,467
Restructuring and severance costs	2,190	169
Net (gain) loss on sale of assets	(31)	60
Operating income	8,628	3,057
Interest expense, net	9,604	2,481
Non-service pension and post-retirement benefit income	(381)	(5,263)
Other (income) expense, net	(571)	504
(Loss) earnings before income taxes	(24)	5,335
Income tax (benefit) expense	(5)	1,307
Net (loss) earnings	$ (19)	$ 4,028
Earnings per share:
Basic earnings per share (in usd per share)	$ (0.00)	$ 0.14
Diluted earnings per share from continuing operations	$ (0.00)
Diluted earnings per share (in usd per share)		$ 0.14
Basic (in shares)	28,117	27,950
Diluted (in shares)	28,117	28,082

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Statement of Comprehensive Income [Abstract]
Net (loss) earnings	$ (19)	$ 4,028
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	2,538	(5,218)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $434 and $228, respectively	1,441	762
Other Comprehensive Income, Other, Net of Tax	(351)	0
Other comprehensive income (loss)	3,628	(4,456)
Comprehensive income (loss)	$ 3,609	$ (428)

XML

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Statement of Cash Flows [Abstract]
Net (loss) earnings	$ (19)	$ 4,028
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	13,154	8,832
Amortization of debt issuance costs	883	442
Provision for doubtful accounts	805	135
Net (gain) loss on sale of assets	(31)	60
Net (gain) loss on derivative instruments	(283)	449
Stock compensation expense	2,003	2,081
Deferred income taxes	(669)	(1,247)
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
Accounts receivable	(14,177)	4,307
Increase (Decrease) in Contract with Customer, Asset	(2,973)	12,973
Inventories	(9,596)	(17,285)
Income tax refunds receivable	12,663	(410)
Operating Right-of-Use Assets	785	915
Other assets	(6,431)	(2,105)
Accounts payable - trade	(1,151)	(612)
Contract liabilities	1,776	(137)
Operating Lease Liabilities	(852)	(899)
Other current liabilities	(2,483)	(10,581)
Income taxes payable	(222)	53
Pension liabilities	936	(1,876)
Increase (Decrease) in Other Noncurrent Liabilities	429	(140)
Net cash provided by operating activities	(5,453)	(1,017)
Cash flows from investing activities:
Expenditures for property, plant & equipment	(5,948)	(6,877)
Payments to Acquire Businesses, Net of Cash Acquired	1,487	0
Other, net	(1,363)	424
Net cash used in investing activities	(8,798)	(6,453)
Cash flows from financing activities:
Proceeds from (Repayments of) Other Long-Term Debt	(46,000)	0
Proceeds from (Repayments of) Lines of Credit	94,000	0
Purchase of treasury shares	(503)	(575)
Dividends paid	(5,606)	(5,572)
Other, net	2,079	2,112
Net cash provided by (used in) financing activities	43,970	(4,035)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	29,719	(11,505)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	113	(198)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	53,986
Cash and cash equivalents at end of period	53,986	129,097
Payments to Acquire Businesses, Net of Cash Acquired	1,487	0
Net (loss) earnings	$ (19)	$ 4,028

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 274,458	$ 268,089
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock, par value (in usd per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	200,000	200,000
Preferred Stock, Shares Outstanding	0	0
Common stock, par value (in usd per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	30,766,419	30,640,068
Treasury Stock, Common, Shares	2,632,334	2,607,841

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Statement of Comprehensive Income [Abstract]
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax	$ 434	$ 228
Net (loss) earnings	(19)	4,028
Foreign currency translation adjustments	2,538	(5,218)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $434 and $228, respectively	1,441	762
Other Comprehensive Income, Other, Net of Tax	(351)	0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(91)	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	3,628	(4,456)
Comprehensive income (loss)	3,609	(428)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	$ 106	$ 0

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

BASIS OF PRESENTATION

In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The first quarters for 2023 and 2022 ended on March 31, 2023, and April 1, 2022, respectively.

XML

Business Combinations

3 Months Ended

Mar. 31, 2023

Acquisitions [Abstract]

Business Combination Disclosure

. BUSINESS COMBINATIONS AND INVESTMENTS

Aircraft Wheel & Brake

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker-Hannifin Corporation's ("Parker") Aircraft Wheel and Brake division, of Avon, Ohio, at a purchase price of $442.8 million. Aircraft Wheel and Brake is a leader in the design, development, qualification, manufacturing and assembly, product support and repair of wheels, brakes and related hydraulic components for fixed-wing aircraft and rotorcraft. With this acquisition, the Company has expanded its portfolio of engineered products, broadening the number of offerings available to serve customers across a range of critical applications and has increased the Company's exposure within the aerospace and defense end markets.

This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands):

Accounts receivable	$	7,635
Contract assets	171
Inventories	11,246
Property, plant and equipment	7,686
Goodwill	171,277
Other intangible assets(1)	250,500
Contract costs, noncurrent	41
Liabilities	(5,729)
Net assets acquired	442,827
Less cash received	—
Net consideration	$	442,827

(1)Refer to Note 3, Business Combinations and Investments, in the Annual Report on Form 10-K for the year ended December 31, 2022 for information on the Company's determination of the fair value of identifiable assets.

During the first quarter of 2023, the Company paid Parker an additional $1.5 million for the working capital adjustment, which resulted in an increase to goodwill. All purchase price allocations were finalized within the one-year measurement period and no further adjustments are expected.

The goodwill associated with this acquisition is tax deductible and is the result of expected synergies from combining the operations of the acquired business with the Company's operations and intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill associated with this acquisition was recognized in the Engineered Products segment.

Aircraft Wheel and Brake's results of operations have been included in the Company's financial statements for the period subsequent to the completion of the acquisition on September 16, 2022. Aircraft Wheel and Brake contributed $18.5 million of revenue and $0.8 million of operating income for the three-month fiscal period ended March 31, 2023.

XML

Segment and Geographic Information (Notes)

3 Months Ended

Mar. 31, 2023

Revenue [Abstract]

Segment Reporting Disclosure

. REVENUE AND SEGMENT INFORMATION

The Company is organized based upon the nature of its products and services, and is composed of three operating segments, each overseen by a segment manager. These segments are reflective of how the Company’s Chief Executive Officer, who is its Chief Operating Decision Maker ("CODM"), reviews operating results for the purposes of allocating resources and assessing performance. The Company has not aggregated operating segments for purposes of identifying reportable segments.

The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters and fixed-wing and unmanned aerial vehicle ("UAV") aircraft.

The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; support of the heavy lift K-MAX® manned helicopter; and development of the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.

Summarized financial information by business segment is as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Net sales:
Engineered Products	$	123,326	$	81,452
Precision Products	37,971		47,549
Structures	33,245		29,047
Net sales	$	194,542	$	158,048
Operating income (loss):
Engineered Products	$	19,356	$	11,042
Precision Products	1,674		3,409
Structures	(237)		(617)
Corporate expense	(10,006)		(10,548)
Other unallocated expenses, net(1)	(2,159)		(229)
Operating income	$	8,628	$	3,057
Interest expense, net	9,604		2,481
Non-service pension and post retirement benefit income, net	(381)		(5,263)
Other (income) expense, net	(571)		504
(Loss) earnings before income taxes	$	(24)	$	5,335

(1) Other unallocated expenses, net include restructuring and severance costs and net (gain) loss on sale of assets.

3. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue

The following tables disaggregate segment revenue by major product line:

	For the Three Months Ended
	March 31, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	20,023	$	5,586	$	18,805	$	44,414
Safe and Arm Devices	—		26,242		—		26,242
Commercial, Business & General Aviation	59,685		5,013		12,504		77,202
Medical	24,935		—		1,936		26,871
Industrial & Other	18,683		1,130		—		19,813
Total revenue	$	123,326	$	37,971	$	33,245	$	194,542
	For the Three Months Ended
	April 1, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	9,653	$	5,322	$	16,255	$	31,230
Safe and Arm Devices	—		37,322		—		37,322
Commercial, Business & General Aviation	32,378		3,767		10,813		46,958
Medical	21,149		—		1,979		23,128
Industrial & Other	18,272		1,138		—		19,410
Total revenue	$	81,452	$	47,549	$	29,047	$	158,048

The following table disaggregates total revenue by product types.

	For the Three Months Ended
	March 31, 2023
	Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	45	%	2	%	17	%	64	%
Aftermarket	18	%	5	%	—	%	23	%
Safe and Arm Devices	—	%	13	%	—	%	13	%
Total revenue	63	%	20	%	17	%	100	%
	For the Three Months Ended
	April 1, 2022
	Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	41	%	2	%	18	%	61	%
Aftermarket	11	%	4	%	—	%	15	%
Safe and Arm Devices	—	%	24	%	—	%	24	%
Total revenue	52	%	30	%	18	%	100	%

3. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Research and Development Costs

The following table presents research and development costs by segment:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Engineered Products	$	2,439	$	2,243
Precision Products	3,458		2,803
Structures	10		67
Total research and development costs	$	5,907	$	5,113

Other

For contracts in which revenue is recognized over time, the Company performs detailed quarterly reviews of the progress and execution of its performance obligations under these contracts. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and cost to achieve the schedule (e.g., the number and type of milestone events), technical requirements (e.g., a newly-developed product versus a mature product) and other contract requirements. Management must make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation (e.g., to estimate increases in wages and prices for materials and related support cost allocations), execution by subcontractors, the availability and timing of funding from customers and overhead cost rates, among other variables. Based upon these reviews, the Company will record the effects of adjustments in profit estimates each period. If at any time management determines that in the case of a particular contract total costs will exceed total contract revenue, a provision for the entire anticipated contract loss is recorded at that time.

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Net (decrease) increase in revenue due to change in profit estimates	$	(1,269)	$	905

In the three-month fiscal period ended March 31, 2023, the net decrease in revenue was primarily related to cost growth on certain structures and precision products contracts, partially offset by favorable cost performance on the joint programmable fuze ("JPF") contract with the U.S. Government ("USG") and the JASSM contract. In the three-month fiscal period ended April 1, 2022, the net increase in revenue was primarily related to favorable cost performance on the JPF contract with the USG, partially offset by cost growth on certain structures programs and legacy fuzing contracts.

3. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Unfulfilled Performance Obligations

Unfulfilled performance obligations ("backlog") represents the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts. Backlog at March 31, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows:

	March 31, 2023(1)		December 31, 2022
	(in thousands)
Engineered Products	$	369,713	$	322,452
Precision Products	111,750		134,903
Structures	251,531		263,581
Total Backlog	$	732,994	$	720,936

(1) The Company expects to recognize revenue on approximately 73% of backlog as of March 31, 2023 over the next twelve months.

XML

Restructuring Costs

3 Months Ended

Mar. 31, 2023

Restructuring Costs [Abstract]

Restructuring Costs

. RESTRUCTURING AND SEVERANCE COSTS

Restructuring and severance costs are included in restructuring and severance costs on the Company's Condensed Consolidated Statements of Operations and other unallocated expenses, net within in Note 3, Revenue and Segment Information.

Transformation Restructuring

In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improve working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result of this review, the Company identified areas to reduce annualized costs in the Precision Products segment and at Corporate through streamlining processes, consolidating the production of fuzes for the JPF program at its Middletown facility, discontinuing K-MAX® helicopter production and right-sizing the Company's total cost structure. In the three-month fiscal period ended March 31, 2023, the Company incurred $2.2 million in severance costs associated with these actions. Of this amount, $0.3 million was related to share-based compensation expense.

The following table summarizes the accrual balances by cost type for the restructuring actions:

	Severance		Other(1)		Total
In thousands
Restructuring accrual balance at December 31, 2022(2)	$	6,629	$	—	$	6,629
Provision	1,730		136		1,866
Cash payments	(3,616)		(136)		(3,752)
Changes in foreign currency exchange rates	25		—		25
Restructuring accrual balance at March 31, 2023(2)	$	4,768	$	—	$	4,768

(1) Includes costs associated with the consolidation of facilities.

(2) Of the above accrual balance, $1.0 million was included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022. The remainder is included in other current liabilities.

XML

Accounts Receivable, Net

3 Months Ended

Mar. 31, 2023

Accounts Receivable, after Allowance for Credit Loss [Abstract]

Accounts Receivable, Net

ACCOUNTS RECEIVABLE, NET

Accounts receivable, net consisted of the following:

	March 31, 2023		December 31, 2022
In thousands
Trade receivables	$	41,989	$	31,126
U.S. Government contracts:
Billed	15,576		14,150
Cost and accrued profit - not billed	1,588		661
Commercial and other government contracts
Billed	42,615		41,520
Cost and accrued profit - not billed	2,268		2,268
Less allowance for doubtful accounts	(2,744)		(2,066)
Accounts receivable, net	$	101,292	$	87,659

The Company performs ongoing evaluations of its customers’ current creditworthiness, as determined by the review of their credit information, to determine if events have occurred subsequent to the recognition of revenue and the related receivable that provide evidence that such receivable will be realized in an amount less than that recognized at the time of sale. Estimates of credit losses are based on historical losses, current economic conditions, geographic considerations, and in some cases, evaluating specific customer accounts for risk of loss.

The following table summarizes the activity in the allowance for doubtful accounts in the three-month fiscal period ended March 31, 2023:

In thousands
Balance at December 31, 2022	$	(2,066)
Provision	(805)
Amounts written off	57
Recoveries	71
Changes in foreign currency exchange rates	(1)
Balance at March 31, 2023	$	(2,744)

There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

XML

Contract Assets, Contract Costs and Contract Liabilities

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Contract Assets, Contract Costs and Contract Liabilities

Activity related to contract assets, contract costs and contract liabilities was as follows:

	March 31, 2023		December 31, 2022		$ Change		% Change
In thousands
Contract assets	$	116,168	$	113,182	$	2,986	2.6	%
Contract costs, current portion(1)	$	531	$	695	$	(164)	(23.6)	%
Contract costs, noncurrent portion(2)	$	693	$	673	$	20	3.0	%
Contract liabilities, current portion	$	6,044	$	4,081	$	1,963	48.1	%
Contract liabilities, noncurrent portion	$	20,329	$	20,515	$	(186)	(0.9)	%

(1) Contract costs, current portion are included within other current assets on the Company's Condensed Consolidated Balance Sheets.

(2) Contract costs, noncurrent portion are included within other assets on the Company's Condensed Consolidated Balance Sheets.

Contract Assets

The increase in contract assets was primarily due to the recognition of revenue related to the satisfaction or partial satisfaction of performance obligations for work performed and not yet billed on certain programs with Boeing and the AH-1 blade program compared to lower amounts billed in the current period on the JPF program. There were no significant impairment losses related to the Company's contract assets during the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

There were no amounts included in contract assets for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

Contract Costs

At March 31, 2023 and December 31, 2022, costs to fulfill a contract were $1.2 million and $1.4 million, respectively. These amounts were included in other current assets and other assets on the Company's Condensed Consolidated Balance Sheets at March 31, 2023 and December 31, 2022. There were no costs to obtain a contract at March 31, 2023 and December 31, 2022.

Contract costs, current portion at March 31, 2023 decreased compared to the balance at December 31, 2022. This was primarily attributable to the amortization of contract costs. Amortization of contract costs was $0.1 million for the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Contract costs, noncurrent portion at March 31, 2023 remained relatively flat when compared to the balance at December 31, 2022.

Contract Liabilities

Contract liabilities, current portion at March 31, 2023 increased compared to the balance at December 31, 2022. This was primarily due to advances received for the SH-2G program with New Zealand and the reclassification of liabilities on the FireburstTM enhanced fuzing capability program from contract liabilities, noncurrent portion, partially offset by revenue recognized on the JASSM® program. Revenue recognized related to contract liabilities, current portion was $0.5 million in the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Contract liabilities, noncurrent portion at March 31, 2023 decreased compared to the balance at December 31, 2022 due to the reclassification of liabilities on the FireBurstTM enhanced fuzing capability program to contract liabilities, current portion, partially offset by advances received for the JPF program. For the three-month fiscal periods ended March 31, 2023 and April 1, 2022, the Company did not recognize revenue against contract liabilities, noncurrent portion. Refer to Note 12, Commitments and Contingencies, for further information on the Company's offset agreements.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.

The Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: 

•Level 1 — Quoted prices in active markets for identical assets or liabilities.

•Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.

•Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table presents the carrying value and fair value of financial instruments that are not carried at fair value:

	March 31, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
In thousands
Debt (1)	$	610,500	$	592,533	$	562,500	$	547,393

(1) These amounts are classified within Level 2.

The above fair values were computed based on quoted market prices and discounted future cash flows (observable inputs), as applicable. Differences from carrying values are attributable to interest rate changes subsequent to when the transactions occurred.

The fair values of cash and cash equivalents, accounts receivable, net and accounts payable - trade approximate their carrying amounts due to the short-term maturities of these instruments. The Company's cash and cash equivalents at March 31, 2023 and December 31, 2022 included $35.1 million and $0.1 million, respectively, of Level 1 money market funds.

Recurring Fair Value Measurements

The Company holds derivative instruments for foreign exchange contracts and interest rate swaps that are measured at fair value using observable market inputs such as forward rates and its counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At March 31, 2023, the interest rate swaps were included in other current liabilities and other long-term liabilities on the Company's Condensed Consolidated Balance Sheets. At March 31, 2023 and December 31, 2022, the foreign exchange contracts were included in other current assets and other current liabilities on the Company's Condensed Consolidated Balance Sheets. Based on the Company's continued ability to trade and enter into forward contracts and interest rate swaps, the Company considers the markets for its fair value instruments to be active.

The Company evaluated the credit risk associated with the counterparties to these derivative instruments and determined that as of March 31, 2023, such credit risks had not had an adverse impact on the fair value of these instruments.

XML

Derivative Financial Instruments

3 Months Ended

Mar. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

DERIVATIVE FINANCIAL INSTRUMENTSThe Company is exposed to certain risks relating to its ongoing business operations, including market risks relating to fluctuations in foreign currency exchange rates and interest rates. Derivative financial instruments are recognized on the Condensed Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair values of derivatives are recorded each period in earnings or accumulated other comprehensive income, depending on whether a derivative is effective as part of a hedged transaction. Gains and losses on derivative instruments reported in accumulated other comprehensive income (loss) are subsequently included in earnings in the periods in which earnings are affected by the hedged item. The Company does not use derivative instruments for speculative purposes.

8. DERIVATIVE FINANCIAL INSTRUMENTS (CONTINUED)

Cash Flow Hedges

Interest Rate Swaps

The Company's Credit Agreement (as defined in "Management's Discussion and Analysis of Financial Condition and Results of Operations" below) contains floating rate obligations and is subject to interest rate fluctuations. In late 2022, the Company entered into interest rate swap agreements with a notional value of $200.0 million, effective January 1, 2023, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These interest rate swap agreements were designated as cash flow hedges and intended to manage interest rate risk associated with the Company's variable-rate borrowings and minimize the impact on earnings and cash flows of interest rate fluctuations attributable to changes in the Secured Overnight Financing Rate. These interest rate swaps were not material to the Company's Condensed Consolidated Financial Statements for the three-month fiscal period ended March 31, 2023. Over the next twelve months, the income related to cash flow hedges expected to be reclassified from other comprehensive income is $0.3 million.

Forward Exchange Contracts

The Company holds forward exchange contracts designed to hedge forecasted transactions denominated in foreign currencies and to minimize the impact of foreign currency fluctuations on the Company’s earnings and cash flows. These contracts were not material to the Company's Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022. The activity related to these contracts was not material to the Company's Condensed Consolidated Financial Statements for the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

XML

Inventories

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories consisted of the following:

	March 31, 2023		December 31, 2022
In thousands
Raw materials	$	27,595	$	25,798
Contracts and other work in process (including certain general stock materials)	124,953		110,609
Finished goods	33,947		40,061
Inventories	$	186,495	$	176,468

There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

At March 31, 2023 and December 31, 2022, $25.6 million and $24.7 million, respectively, of K-MAX® inventory was included in contracts and other work in process inventory and finished goods on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $23.4 million of the K-MAX® inventory will be sold after March 31, 2024, based upon the requirements to support the fleet for the foreseeable future. In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improving working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result, the Company determined it would discontinue K-MAX® aircraft production and wrote off $44.5 million of inventory associated with the program as of December 31, 2022. There were no additional inventory write-offs for the period ended March 31, 2023; however, production material for the K-MAX® includes long lead parts, which the Company evaluates for alternative use as received. Any write-offs related to these parts are not expected to have a material adverse effect on the Company's results of operations or financial position.

At March 31, 2023 and December 31, 2022, $6.4 million and $6.2 million, respectively, of SH-2G(I) inventory was included in contracts and other work in process inventory on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $5.3 million of the SH-2G(I) inventory will be sold after March 31, 2024. This balance represents spares requirements and inventory to be used on SH-2G programs.

XML

Goodwill and Other Intangible Assets, Net

3 Months Ended

Mar. 31, 2023

Intangible Assets, Net (Including Goodwill) [Abstract]

Goodwill and Other Intangible Assets, Net

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company:

	Engineered Products		Precision Products		Structures		Total
In thousands
Gross balance at December 31, 2022	$	363,785	$	41,375	$	66,559	$	471,719
Accumulated impairment	—		(25,306)		(66,559)		(91,865)
Net balance at December 31, 2022	363,785		16,069		—		379,854
Additions	1,487		—		—		1,487
Impairments	—		—		—		—
Foreign currency translation	1,163		—		—		1,163
Ending balance at March 31, 2023	$	366,435	$	16,069	$	—	$	382,504
Accumulated impairment at end of period	$	—	$	(25,306)	$	(66,559)	$	(91,865)

Other Intangible Assets

Other intangible assets consisted of:

		At March 31,				At December 31,
		2023				2022
	Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
In thousands
Customer lists / relationships	6-38 years	$	363,846	$	(45,025)	$	363,549	$	(41,695)
Developed technologies	7-20 years	45,139		(18,615)		45,028		(17,508)
Trademarks / trade names	15-40 years	16,747		(3,339)		16,681		(3,153)
Non-compete agreements and other	1-15 years	17,356		(10,745)		17,336		(7,974)
Patents	17 years	551		(488)		551		(484)
Total intangible assets		$	443,639	$	(78,212)	$	443,145	$	(70,814)

XML

Pension Plans

3 Months Ended

Mar. 31, 2023

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Compensation and Employee Benefit Plans

PENSION PLANS

Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows:

	For the Three Months Ended
	Qualified Pension Plan				SERP
	March 31, 2023		April 1, 2022		March 31, 2023		April 1, 2022
In thousands
Service cost	$	1,450	$	800	$	—	$	—
Interest cost on projected benefit obligation	7,250		4,250		44		22
Expected return on plan assets	(9,550)		(10,525)		—		—
Amortization of net loss	1,875		975		—		15
Net pension cost (income)	$	1,025	$	(4,500)	$	44	$	37

11. PENSION PLANS (CONTINUED)

No contributions are expected to be made to the qualified pension plan during 2023. The Company contributed $0.1 million to the SERP through the end of the first quarter of 2023 and plans to contribute an additional $0.4 million to the SERP in 2023. No contributions were made to the qualified pension plan during 2022. For the 2022 plan year, the Company contributed $0.5 million to the SERP.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

New Hartford Property

In connection with the sale of the Company’s Music segment in 2007, the Company assumed responsibility for meeting certain requirements of the Connecticut Transfer Act (the “Transfer Act”) that applied to the transfer of the New Hartford, Connecticut, facility leased by that segment for guitar manufacturing purposes (“Ovation”). Under the Transfer Act, those responsibilities essentially consist of assessing the site's environmental conditions and remediating environmental impairments, if any, caused by Ovation's operations prior to the sale. The site is a multi-tenant industrial park, in which Ovation and other unrelated entities lease space. The environmental assessment process, which began in 2008, has been completed and site remediation is in process.

The Company's estimate of its portion of the cost to assess the environmental conditions and remediate this site is $2.3 million, all of which has been accrued. The remediation has been nearly completed and the Company continues to monitor the results of the remediation. The total amount paid to date in connection with these environmental remediation activities is $1.8 million. At March 31, 2023, the Company had $0.5 million accrued for these environmental remediation activities. A portion ($0.1 million) of the accrual related to this property is included in other current liabilities and the balance is included in other long-term liabilities. The remaining balance of the accrual reflects the total anticipated cost of completing these environmental remediation activities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

Bloomfield Property

In connection with the Company’s 2008 purchase of the portion of the Bloomfield campus that Kaman Aerospace Corporation had leased from NAVAIR, the Company assumed responsibility for environmental remediation at the facility as may be required under the Transfer Act and is currently remediating the property under the guidance of the Connecticut Department of Environmental Protection. The assumed environmental liability of $10.3 million was determined by taking the undiscounted estimated remediation liability of $20.8 million and discounting it at a rate of 8%. This remediation process will take many years to complete. The total amount paid to date in connection with these environmental remediation activities is $15.4 million. At March 31, 2023, the Company had $2.1 million accrued for these environmental remediation activities. A portion ($0.2 million) of the accrual related to this property is included in other current liabilities, and the balance is included in other long-term liabilities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

Offset Agreement

The Company has entered into offset agreements as a condition to obtaining orders from a Middle Eastern customer for the Company's JPF product. Offset agreements are designed to return economic value to the foreign country by requiring the Company to engage in activities supporting local defense or commercial industries, promoting a balance of trade, developing in-country technology capabilities or addressing other local development priorities. Such agreements may be satisfied through activities that do not require a direct cash payment, including transferring technology, providing manufacturing, training and other consulting support to in-country projects and the purchase by third parties of supplies from in-country vendors. The agreements may also be satisfied through the Company's use of cash for activities, such as subcontracting with local partners, purchasing supplies from in-country vendors, providing financial support for in-country projects and making investments in local ventures. At March 31, 2023, the aggregate amount of the Company's offset agreements had an outstanding notional value of approximately $220.9 million, which is equal to sixty percent of the contract value as defined by the agreement between the customer and the Company. The amount ultimately applied against offset agreements is based on negotiations with the customer and may require cash outlays that represent only a fraction of the notional value in the offset agreement.

12. COMMITMENTS AND CONTINGENCIES (CONTINUED)

Offset Agreement - continued

The Company continues to work with the customer to further define the requirements to satisfy the offset agreements. In February 2023, the Company announced that it received a Business Plan Approval Letter to establish a manufacturing and final assembly facility in collaboration with an in-country vendor, which will enhance the technological capabilities available in this country. Offset programs typically extend over several years and may provide for penalties in the event the Company fails to perform according to offset requirements. The satisfaction of the offset requirements will be determined by the customer. In the event the offset requirements of the contract are not met, the Company could be liable for potential penalties up to $18.8 million payable to the customer. Failure to satisfy the offset requirements could also negatively impact the Company's ability to attract future orders from this customer. The Company considers these potential penalties to be a reduction to the transaction price in its determination of the value of the performance obligations within these contracts. At March 31, 2023, $18.8 million in contract liabilities associated with the potential penalties of the offset requirements were included on the Company's Condensed Consolidated Balance Sheets.

Guarantees

During 2020, the Company and the USG entered into a Guaranty Agreement, pursuant to which the Company agreed to guarantee the full, complete and satisfactory performance of its subsidiary, Kaman Precision Products, Inc. ("KPPI") under all current and future contracts with the USG. As of the date of this filing, the only contract in place between KPPI and the USG relates to the production and sale of the JPF. KPPI is currently fulfilling the requirements of Option 16. The guarantee was provided in lieu of a periodic financial capability review by the Financial Capacity Team ("FCT") of the Defense Contract Management Agency ("DCMA"). The Company is unable to estimate the maximum potential amount of future payments under the guarantee as it is dependent on costs incurred by the USG in the event of default. Although the Company believes the risk of default is low given the maturity and operational performance of the JPF program, there can be no assurance that the guarantee will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker's Aircraft Wheel and Brake division. In association with the acquisition, the Company entered into a novation agreement in which Parker's contractual obligations with respect to Aircraft Wheel and Brake at the time of the acquisition were transferred to the Company. There can be no assurance that this agreement will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

XML

Computation of Earnings Per Share

3 Months Ended

Mar. 31, 2023

Earnings Per Share Reconciliation [Abstract]

Computation of Earnings Per Share

COMPUTATION OF EARNINGS PER SHARE

The computation of basic earnings per share is based on net earnings divided by the weighted average number of shares of common stock outstanding for each period. The computation of diluted earnings per share reflects the common stock equivalency of dilutive options granted to employees under the Company's stock incentive plan, shares issuable on redemption of its convertible notes and shares issuable upon redemption of outstanding warrants.

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands, except per share amounts
Net (loss) earnings	$	(19)	$	4,028
Basic:
Weighted average number of shares outstanding	28,117		27,950
Basic (loss) earnings per share	$	(0.00)	$	0.14
Diluted:
Weighted average number of shares outstanding	28,117		27,950
Weighted average shares issuable on exercise of dilutive stock options	—		132
Total	28,117		28,082
Diluted (loss) earnings per share	$	(0.00)	$	0.14

Equity awards

For the three-month fiscal periods ended March 31, 2023 and April 1, 2022, respectively, 698,648 and 645,403 shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods.

All outstanding stock awards were excluded in the computation of diluted earnings per share in the three-month fiscal period ended March 31, 2023 because their effect was antidilutive due to the net loss. For the three-month fiscal periods ended March 31, 2023, an additional 149,699 shares issuable under equity awards, which would have been dilutive if exercised based on the average market price being higher than the exercise price, were excluded from the computation of diluted earnings per share as their effect was antidilutive due to the net loss.

2024 Convertible Notes

For both three-month fiscal periods ended March 31, 2023 and April 1, 2022, 3,056,879 shares issuable under Convertible Notes due 2024 were excluded from the diluted earnings per share calculation because their effect was antidilutive.

XML

Share-based Arrangements

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Share-based Payment Arrangement

14. SHARE-BASED ARRANGEMENTS

The Company accounts for stock options, restricted stock awards ("RSAs"), restricted stock units ("RSUs") and performance stock units ("PSUs") as equity awards and measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the statement of operations. The Company also has an employee stock purchase plan, which is accounted for as a liability award. Compensation expense for stock options, RSAs, RSUs and PSUs is recognized on a straight-line basis over the vesting period of the awards. Throughout the course of the vesting period, the Company monitors the achievement level for the return on invested capital ("ROIC") metric of the PSUs compared to the ROIC target and adjusts the number of shares expected to be earned, and the related compensation expense recorded thereafter, to reflect the most probable outcome. The PSUs granted in 2023 and 2022 assumed a 100% achievement level. Share-based compensation expense recorded for the three-month fiscal periods ended March 31, 2023 and April 1, 2022 was $2.0 million and $2.1 million, respectively. For the three-month fiscal period ended March 31, 2023, $0.3 million was recorded to restructuring and severance costs and the remaining amount was recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations.

14. SHARE-BASED ARRANGEMENTS (CONTINUED)

Stock option activity was as follows:

	For the Three Months Ended
	March 31, 2023
	Options	Weighted - average exercise price
Options outstanding at beginning of period	710,782	$	54.12
Granted	—	$	—
Exercised	—	$	—
Forfeited or expired	(24,061)	$	43.07
Options outstanding at March 31, 2023	686,721	$	54.51

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. No options were granted in the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Restricted stock award and restricted stock unit activity were as follows:

	For the Three Months Ended
	March 31, 2023
	Restricted  Stock	Weighted- average grant date fair value
Restricted Stock outstanding at beginning of period	159,521	$	45.78
Granted	102,600	$	25.24
Vested	(62,488)	$	47.14
Forfeited or expired	(4,366)	$	47.51
Restricted Stock outstanding at March 31, 2023	195,267	$	34.51

Performance stock unit activity was as follows:

	For the Three Months Ended
	March 31, 2023
	Performance Stock	Weighted- average grant date fair value
Performance Stock outstanding at beginning of period	172,144	$	60.44
Granted	178,385	$	32.03
Vested	—	$	—
Forfeited or expired	(30,345)	$	56.88
Performance Stock outstanding at March 31, 2023	320,184	$	44.95

The fair value of the PSUs based on total shareholder return ("TSR") was estimated on the date of grant using a Monte-Carlo simulation model. The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Three Months Ended
	March 31, 2023			April 1, 2022
Expected term (years)	2.9			2.9
Expected volatility	41.2		%	39.4		%
Risk-free interest rate	4.4		%	1.7		%
Expected dividend yield	3.3		%	1.9		%
Per share fair value of performance stock granted	$	38.83		$	68.10

XML

Shareholders' Equity and Accumulated Other Comprehensive Income

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Shareholders' Equity and Accumulated Other Comprehensive Income

SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in shareholders’ equity for the three-month fiscal periods ended March 31, 2023, and April 1, 2022, were as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Beginning balance	$	683,979	$	796,329
Comprehensive income (loss)	3,609		(428)
Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	(5,627)		(5,590)
Employee stock plans and related tax benefit	495		785
Purchase of treasury shares	(503)		(575)
Share-based compensation expense	2,003		2,081
Impact of change in accounting standard(1)	—		(5,854)
Ending balance	$	683,956	$	786,748

(1) At January 1, 2022, the Company adopted Accounting Standard Update 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity" ("ASU 2020-06"). Refer to Note 1, Summary of Significant Accounting Policies, of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 for further information on the adoption of ASU 2020-06.

The components of accumulated other comprehensive income (loss) are shown below:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Foreign currency translation:
Beginning balance	$	(2,071)	$	8,765
Net gain (loss) on foreign currency translation	2,538		(5,218)
Other comprehensive income (loss), net of tax	2,538		(5,218)
Ending balance	$	467	$	3,547
Pension and other post-retirement benefits(1):
Beginning balance	$	(156,350)	$	(120,157)
Amortization of net loss, net of tax expense of $434 and $228, respectively	1,441		762
Other comprehensive income, net of tax	1,441		762
Ending balance	$	(154,909)	$	(119,395)
Derivative instruments(2):
Beginning balance	$	—	$	7
Loss on derivative instruments, net of tax benefit of $78 and $0, respectively	(260)		—
Reclassification to net income, net of tax benefit of $28 and $0, respectively	$	(91)	$	—
Other comprehensive (loss) income, net of tax	(351)		—
Ending balance	$	(351)	$	7
Total accumulated other comprehensive loss	$	(154,793)	$	(115,841)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 11, Pension Plans, for additional information.)

(2) See Note 8, Derivative Financial Instruments, for additional information regarding derivative instruments.

XML

Income Taxes

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

	For the Three Months Ended
	March 31, 2023		April 1, 2022
Effective Income Tax Rate	20.8	%	24.5	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings for the period. The decrease in the effective tax rate for the three-month period ended March 31, 2023 as compared to the corresponding rate in the prior year period was primarily driven by lower net earnings in the current period.

XML

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSThe Company has evaluated subsequent events through the issuance date of these financial statements. No material subsequent events were identified that require disclosure.

XML

Basis of Presentation Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2023

Basis of Presentation [Abstract]

Consolidation, Policy [Policy Text Block]

BASIS OF PRESENTATION

In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The first quarters for 2023 and 2022 ended on March 31, 2023, and April 1, 2022, respectively.

XML

Business Combinations (Tables)

3 Months Ended

Mar. 31, 2023

Acquisitions [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands):

Accounts receivable	$	7,635
Contract assets	171
Inventories	11,246
Property, plant and equipment	7,686
Goodwill	171,277
Other intangible assets(1)	250,500
Contract costs, noncurrent	41
Liabilities	(5,729)
Net assets acquired	442,827
Less cash received	—
Net consideration	$	442,827

XML

Segment and Geographic Information (Tables)

3 Months Ended

Mar. 31, 2023

Revenue [Abstract]

Reconciliation of Revenue from Segments to Consolidated

Summarized financial information by business segment is as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Net sales:
Engineered Products	$	123,326	$	81,452
Precision Products	37,971		47,549
Structures	33,245		29,047
Net sales	$	194,542	$	158,048
Operating income (loss):
Engineered Products	$	19,356	$	11,042
Precision Products	1,674		3,409
Structures	(237)		(617)
Corporate expense	(10,006)		(10,548)
Other unallocated expenses, net(1)	(2,159)		(229)
Operating income	$	8,628	$	3,057
Interest expense, net	9,604		2,481
Non-service pension and post retirement benefit income, net	(381)		(5,263)
Other (income) expense, net	(571)		504
(Loss) earnings before income taxes	$	(24)	$	5,335

(1) Other unallocated expenses, net include restructuring and severance costs and net (gain) loss on sale of assets.

Disaggregation of Revenue [Table Text Block]

Disaggregation of Revenue

The following tables disaggregate segment revenue by major product line:

	For the Three Months Ended
	March 31, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	20,023	$	5,586	$	18,805	$	44,414
Safe and Arm Devices	—		26,242		—		26,242
Commercial, Business & General Aviation	59,685		5,013		12,504		77,202
Medical	24,935		—		1,936		26,871
Industrial & Other	18,683		1,130		—		19,813
Total revenue	$	123,326	$	37,971	$	33,245	$	194,542
	For the Three Months Ended
	April 1, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	9,653	$	5,322	$	16,255	$	31,230
Safe and Arm Devices	—		37,322		—		37,322
Commercial, Business & General Aviation	32,378		3,767		10,813		46,958
Medical	21,149		—		1,979		23,128
Industrial & Other	18,272		1,138		—		19,410
Total revenue	$	81,452	$	47,549	$	29,047	$	158,048

The following table disaggregates total revenue by product types.

	For the Three Months Ended
	March 31, 2023
	Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	45	%	2	%	17	%	64	%
Aftermarket	18	%	5	%	—	%	23	%
Safe and Arm Devices	—	%	13	%	—	%	13	%
Total revenue	63	%	20	%	17	%	100	%
	For the Three Months Ended
	April 1, 2022
	Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	41	%	2	%	18	%	61	%
Aftermarket	11	%	4	%	—	%	15	%
Safe and Arm Devices	—	%	24	%	—	%	24	%
Total revenue	52	%	30	%	18	%	100	%

Research and Development

The following table presents research and development costs by segment:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Engineered Products	$	2,439	$	2,243
Precision Products	3,458		2,803
Structures	10		67
Total research and development costs	$	5,907	$	5,113

Schedule of Change in Accounting Estimate [Table Text Block]

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Net (decrease) increase in revenue due to change in profit estimates	$	(1,269)	$	905

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

Backlog at March 31, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows:

	March 31, 2023(1)		December 31, 2022
	(in thousands)
Engineered Products	$	369,713	$	322,452
Precision Products	111,750		134,903
Structures	251,531		263,581
Total Backlog	$	732,994	$	720,936

(1) The Company expects to recognize revenue on approximately 73% of backlog as of March 31, 2023 over the next twelve months.

^[1]

[1] The Company expects to recognize revenue on approximately 73% of backlog as of March 31, 2023 over the next twelve months.

XML

Restructuring Costs (Tables)

3 Months Ended

Mar. 31, 2023

Restructuring Costs [Abstract]

Restructuring and Related Costs

The following table summarizes the accrual balances by cost type for the restructuring actions:

	Severance		Other(1)		Total
In thousands
Restructuring accrual balance at December 31, 2022(2)	$	6,629	$	—	$	6,629
Provision	1,730		136		1,866
Cash payments	(3,616)		(136)		(3,752)
Changes in foreign currency exchange rates	25		—		25
Restructuring accrual balance at March 31, 2023(2)	$	4,768	$	—	$	4,768

XML

Accounts Receivable, Net (Tables)

3 Months Ended

Mar. 31, 2023

Accounts Receivable, after Allowance for Credit Loss [Abstract]

Schedule of Accounts Receivable, Net

Accounts receivable, net consisted of the following:

	March 31, 2023		December 31, 2022
In thousands
Trade receivables	$	41,989	$	31,126
U.S. Government contracts:
Billed	15,576		14,150
Cost and accrued profit - not billed	1,588		661
Commercial and other government contracts
Billed	42,615		41,520
Cost and accrued profit - not billed	2,268		2,268
Less allowance for doubtful accounts	(2,744)		(2,066)
Accounts receivable, net	$	101,292	$	87,659

Financing Receivable, Allowance for Credit Loss [Table Text Block]

The following table summarizes the activity in the allowance for doubtful accounts in the three-month fiscal period ended March 31, 2023:

In thousands
Balance at December 31, 2022	$	(2,066)
Provision	(805)
Amounts written off	57
Recoveries	71
Changes in foreign currency exchange rates	(1)
Balance at March 31, 2023	$	(2,744)

Accounts Receivable Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Cost

There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

XML

Contract Assets, Contract Costs and Contract Liabilities (Tables)

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Activity Related to Contract Assets, Contract Costs, and Contract Liabilities

Activity related to contract assets, contract costs and contract liabilities was as follows:

	March 31, 2023		December 31, 2022		$ Change		% Change
In thousands
Contract assets	$	116,168	$	113,182	$	2,986	2.6	%
Contract costs, current portion(1)	$	531	$	695	$	(164)	(23.6)	%
Contract costs, noncurrent portion(2)	$	693	$	673	$	20	3.0	%
Contract liabilities, current portion	$	6,044	$	4,081	$	1,963	48.1	%
Contract liabilities, noncurrent portion	$	20,329	$	20,515	$	(186)	(0.9)	%

There were no amounts included in contract assets for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Financial Instruments That Are Not Carried At Fair Value

The following table presents the carrying value and fair value of financial instruments that are not carried at fair value:

	March 31, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
In thousands
Debt (1)	$	610,500	$	592,533	$	562,500	$	547,393

(1) These amounts are classified within Level 2.

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventories consisted of the following:

	March 31, 2023		December 31, 2022
In thousands
Raw materials	$	27,595	$	25,798
Contracts and other work in process (including certain general stock materials)	124,953		110,609
Finished goods	33,947		40,061
Inventories	$	186,495	$	176,468

Inventory Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Contract Costs

There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at March 31, 2023 and December 31, 2022.

XML

Goodwill and Other Intangible Assets, Net (Tables)

3 Months Ended

Mar. 31, 2023

Intangible Assets, Net (Including Goodwill) [Abstract]

Schedule of Goodwill

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company:

	Engineered Products		Precision Products		Structures		Total
In thousands
Gross balance at December 31, 2022	$	363,785	$	41,375	$	66,559	$	471,719
Accumulated impairment	—		(25,306)		(66,559)		(91,865)
Net balance at December 31, 2022	363,785		16,069		—		379,854
Additions	1,487		—		—		1,487
Impairments	—		—		—		—
Foreign currency translation	1,163		—		—		1,163
Ending balance at March 31, 2023	$	366,435	$	16,069	$	—	$	382,504
Accumulated impairment at end of period	$	—	$	(25,306)	$	(66,559)	$	(91,865)

Schedule of Acquired Finite-Lived Intangible Assets by Major Class

Other intangible assets consisted of:

		At March 31,				At December 31,
		2023				2022
	Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
In thousands
Customer lists / relationships	6-38 years	$	363,846	$	(45,025)	$	363,549	$	(41,695)
Developed technologies	7-20 years	45,139		(18,615)		45,028		(17,508)
Trademarks / trade names	15-40 years	16,747		(3,339)		16,681		(3,153)
Non-compete agreements and other	1-15 years	17,356		(10,745)		17,336		(7,974)
Patents	17 years	551		(488)		551		(484)
Total intangible assets		$	443,639	$	(78,212)	$	443,145	$	(70,814)

XML

Pension Plans (Tables)

3 Months Ended

Mar. 31, 2023

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Schedule of Net Benefit Costs

Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows:

	For the Three Months Ended
	Qualified Pension Plan				SERP
	March 31, 2023		April 1, 2022		March 31, 2023		April 1, 2022
In thousands
Service cost	$	1,450	$	800	$	—	$	—
Interest cost on projected benefit obligation	7,250		4,250		44		22
Expected return on plan assets	(9,550)		(10,525)		—		—
Amortization of net loss	1,875		975		—		15
Net pension cost (income)	$	1,025	$	(4,500)	$	44	$	37

XML

Computation of Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share Reconciliation [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands, except per share amounts
Net (loss) earnings	$	(19)	$	4,028
Basic:
Weighted average number of shares outstanding	28,117		27,950
Basic (loss) earnings per share	$	(0.00)	$	0.14
Diluted:
Weighted average number of shares outstanding	28,117		27,950
Weighted average shares issuable on exercise of dilutive stock options	—		132
Total	28,117		28,082
Diluted (loss) earnings per share	$	(0.00)	$	0.14

XML

Share-based Arrangements (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Stock Option Activity

Stock option activity was as follows:

	For the Three Months Ended
	March 31, 2023
	Options	Weighted - average exercise price
Options outstanding at beginning of period	710,782	$	54.12
Granted	—	$	—
Exercised	—	$	—
Forfeited or expired	(24,061)	$	43.07
Options outstanding at March 31, 2023	686,721	$	54.51

Fair Value Assumptions

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. No options were granted in the three-month fiscal periods ended March 31, 2023 and April 1, 2022.

Restricted Stock Award and Restricted Stock Unit Activity

Restricted stock award and restricted stock unit activity were as follows:

	For the Three Months Ended
	March 31, 2023
	Restricted  Stock	Weighted- average grant date fair value
Restricted Stock outstanding at beginning of period	159,521	$	45.78
Granted	102,600	$	25.24
Vested	(62,488)	$	47.14
Forfeited or expired	(4,366)	$	47.51
Restricted Stock outstanding at March 31, 2023	195,267	$	34.51

Share-based Payment Arrangement, Performance Shares, Activity

Performance stock unit activity was as follows:

	For the Three Months Ended
	March 31, 2023
	Performance Stock	Weighted- average grant date fair value
Performance Stock outstanding at beginning of period	172,144	$	60.44
Granted	178,385	$	32.03
Vested	—	$	—
Forfeited or expired	(30,345)	$	56.88
Performance Stock outstanding at March 31, 2023	320,184	$	44.95

Schedule of Share-based Payment Awards, Performance Shares, Valuation Assumptions

The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Three Months Ended
	March 31, 2023			April 1, 2022
Expected term (years)	2.9			2.9
Expected volatility	41.2		%	39.4		%
Risk-free interest rate	4.4		%	1.7		%
Expected dividend yield	3.3		%	1.9		%
Per share fair value of performance stock granted	$	38.83		$	68.10

XML

Shareholders' Equity and Accumulated Other Comprehensive Income (Tables)

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stockholders Equity

Changes in shareholders’ equity for the three-month fiscal periods ended March 31, 2023, and April 1, 2022, were as follows:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Beginning balance	$	683,979	$	796,329
Comprehensive income (loss)	3,609		(428)
Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	(5,627)		(5,590)
Employee stock plans and related tax benefit	495		785
Purchase of treasury shares	(503)		(575)
Share-based compensation expense	2,003		2,081
Impact of change in accounting standard(1)	—		(5,854)
Ending balance	$	683,956	$	786,748

Schedule of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) are shown below:

	For the Three Months Ended
	March 31, 2023		April 1, 2022
In thousands
Foreign currency translation:
Beginning balance	$	(2,071)	$	8,765
Net gain (loss) on foreign currency translation	2,538		(5,218)
Other comprehensive income (loss), net of tax	2,538		(5,218)
Ending balance	$	467	$	3,547
Pension and other post-retirement benefits(1):
Beginning balance	$	(156,350)	$	(120,157)
Amortization of net loss, net of tax expense of $434 and $228, respectively	1,441		762
Other comprehensive income, net of tax	1,441		762
Ending balance	$	(154,909)	$	(119,395)
Derivative instruments(2):
Beginning balance	$	—	$	7
Loss on derivative instruments, net of tax benefit of $78 and $0, respectively	(260)		—
Reclassification to net income, net of tax benefit of $28 and $0, respectively	$	(91)	$	—
Other comprehensive (loss) income, net of tax	(351)		—
Ending balance	$	(351)	$	7
Total accumulated other comprehensive loss	$	(154,793)	$	(115,841)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 11, Pension Plans, for additional information.)

(2) See Note 8, Derivative Financial Instruments, for additional information regarding derivative instruments.

XML

Income Taxes (Tables)

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Effective Income Tax Rates

	For the Three Months Ended
	March 31, 2023		April 1, 2022
Effective Income Tax Rate	20.8	%	24.5	%

XML

Business Combinations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Sep. 16, 2022
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments	$ 1,500
Parker Aircraft Wheels & Brakes
Acquired Indefinite-lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		$ 442,827
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		0
Business Combination, Consideration Transferred	442,827
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables		7,635
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contract Assets		171
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory		11,246
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		7,686
Business Acquisition, Goodwill, Expected Tax Deductible Amount		171,277
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		250,500
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities		41
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		$ (5,729)
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual	18,500
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual	$ 800

XML

Segment and Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 194,542	$ 158,048
Operating Income (Loss)	8,628	3,057
Interest expense, net	9,604	2,481
Non-service pension and post-retirement benefit income	(381)	(5,263)
Other (income) expense, net	$ (571)	$ 504
Revenue, Net, Percentage	100.00%	100.00%
Research and Development Expense	$ 5,907	$ 5,113
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	(24)	5,335
Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	44,414	31,230
Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 26,242	$ 37,322
Revenue, Net, Percentage	13.00%	24.00%
Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 77,202	$ 46,958
Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	26,871	23,128
Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 19,813	$ 19,410
Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	64.00%	61.00%
Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	23.00%	15.00%
Engineered Products
Disaggregation of Revenue [Line Items]
Net sales	$ 123,326	$ 81,452
Operating Income (Loss)	$ 19,356	$ 11,042
Revenue, Net, Percentage	63.00%	52.00%
Research and Development Expense	$ 2,439	$ 2,243
Engineered Products | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	20,023	9,653
Engineered Products | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0	$ 0
Revenue, Net, Percentage	0.00%	0.00%
Engineered Products | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 59,685	$ 32,378
Engineered Products | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	24,935	21,149
Engineered Products | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 18,683	$ 18,272
Engineered Products | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	45.00%	41.00%
Engineered Products | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	18.00%	11.00%
Precision Products
Disaggregation of Revenue [Line Items]
Net sales	$ 37,971	$ 47,549
Operating Income (Loss)	$ 1,674	$ 3,409
Revenue, Net, Percentage	20.00%	30.00%
Research and Development Expense	$ 3,458	$ 2,803
Precision Products | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	5,586	5,322
Precision Products | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 26,242	$ 37,322
Revenue, Net, Percentage	13.00%	24.00%
Precision Products | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 5,013	$ 3,767
Precision Products | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	0	0
Precision Products | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 1,130	$ 1,138
Precision Products | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	2.00%	2.00%
Precision Products | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	5.00%	4.00%
Structures
Disaggregation of Revenue [Line Items]
Net sales	$ 33,245	$ 29,047
Operating Income (Loss)	$ (237)	$ (617)
Revenue, Net, Percentage	17.00%	18.00%
Research and Development Expense	$ 10	$ 67
Structures | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	18,805	16,255
Structures | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0	$ 0
Revenue, Net, Percentage	0.00%	0.00%
Structures | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 12,504	$ 10,813
Structures | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	1,936	1,979
Structures | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0	$ 0
Structures | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	17.00%	18.00%
Structures | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	0.00%	0.00%
Corporate Segment
Disaggregation of Revenue [Line Items]
Operating Income (Loss)	$ (10,006)	$ (10,548)
Other unallocated expenses, net
Disaggregation of Revenue [Line Items]
Operating Income (Loss)	$ (2,159)	$ (229)

XML

Revenue Changes in Revenue due to Estimates in Over Time Contracts (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Change in Accounting Estimate [Line Items]
Net sales	$ 194,542	$ 158,048
Performance obligations satisfied in previous periods [Member]
Change in Accounting Estimate [Line Items]
Reductions in Revenues	$ (1,269)	$ 905

XML

Revenue Unfulfilled Performance Obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	$ 732,994	$ 720,936
Revenue, Remaining Performance Obligation, Percentage	73.00%
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 732,994	720,936
Engineered Products
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	369,713	322,452
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	369,713	322,452
Precision Products
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	111,750	134,903
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	111,750	134,903
Structures
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	251,531	263,581
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 251,531	$ 263,581

XML

Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and severance costs	$ 2,190	$ 169
Restructuring accrual, beginning balance			$ 6,629
Increase (Decrease) in Restructuring Reserve	1,866
Restructuring Reserve, Period Increase (Decrease)	(3,752)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)	25
Restructuring accrual, ending balance	4,768
Share-based compensation expense	2,003	$ 2,081
Restructuring accrual, long-term portion	1,000		1,000
Restructuring and Severance
Restructuring Cost and Reserve [Line Items]
Share-based compensation expense	300
Transformation severance
Restructuring Cost and Reserve [Line Items]
Restructuring and severance costs	2,200
Restructuring accrual, beginning balance			6,629
Increase (Decrease) in Restructuring Reserve	1,730
Restructuring Reserve, Period Increase (Decrease)	(3,616)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)	25
Restructuring accrual, ending balance	4,768
Transformation other
Restructuring Cost and Reserve [Line Items]
Restructuring accrual, beginning balance			$ 0
Increase (Decrease) in Restructuring Reserve	136
Restructuring Reserve, Period Increase (Decrease)	(136)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)	0
Restructuring accrual, ending balance	$ 0

XML

Accounts Receivable, Net - Schedule of Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less allowance for doubtful accounts	$ (2,744)	$ (2,066)
Accounts receivable, net	101,292	87,659
Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	41,989	31,126
U.S. Government contracts | Billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	15,576	14,150
U.S. Government contracts | Not billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	1,588	661
Commercial and other government contracts | Billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	42,615	41,520
Commercial and other government contracts | Not billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	$ 2,268	$ 2,268

XML

Accounts Receivable, Net Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Allowance for Doubtful Accounts [Abstract]
Less allowance for doubtful accounts	$ (2,744)	$ (2,066)
Provision for Other Credit Losses	(805)
Accounts Receivable, Allowance for Credit Loss, Writeoff	57
Accounts Receivable, Allowance for Credit Loss, Recovery	71
Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation	$ (1)

XML

Accounts Receivable, Net - Accounts Receivable due to contract changes, negotiated settlements and claims for unanticipated cost (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Contracts Receivable, Claims and Uncertain Amounts	$ 0	$ 0

XML

Contract Assets, Contract Costs and Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Contract assets	$ 116,168		$ 113,182
Contract assets, change	$ 2,986
Contract assets, change (as percent)	2.60%
Capitalized Contract Cost, Net, Current	$ 531		695
Capitalized costs, current portion, change	$ (164)
Capitalized costs, current portion, change (as percent)	(23.60%)
Capitalized Contract Cost, Net, Noncurrent	$ 693		673
Capitalized costs, noncurrent portion, change	$ 20
Capitalized costs, noncurrent portion, change (as percent)	3.00%
Contract liabilities, current portion	$ 6,044		4,081
Contract liabilities, current portion, change	$ 1,963
Contract liabilities, current portion, change (as percent)	48.10%
Contract liabilities, noncurrent portion	$ 20,329		20,515
Contract liabilities, noncurrent portion, change	$ (186)
Contract liabilities, noncurrent portion, change (as percent)	(0.90%)
Capitalized contract cost, amortization	$ 100	$ 100
Revenue recognized related to contract liabilities	500	$ 500
Contract Changes Negotiated Settlements and Claims [Member]
Disaggregation of Revenue [Line Items]
Contract assets	0		0
Costs to Fulfill [Member]
Disaggregation of Revenue [Line Items]
Capitalized Contract Cost, Net	1,200		1,400
Costs to Obtain [Member]
Disaggregation of Revenue [Line Items]
Capitalized Contract Cost, Net	$ 0		$ 0

XML

Fair Value Measurements - Fair Value of Financial Instruments not carried at Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Money Market Funds, at Carrying Value	$ 35,100	$ 100
Goodwill, Impairment Loss	0
Level 2 | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	610,500	562,500
Level 2 | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	$ 592,533	$ 547,393

XML

Derivative Financial Instruments (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative, Notional Amount	$ 200.0
Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months	$ 0.3

XML

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 27,595	$ 25,798
Contracts and other work in process (including certain general stock materials)	124,953	110,609
Finished goods	33,947	40,061
Inventories	$ 186,495	$ 176,468

XML

Inventories - Inventory Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Contract Costs (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventory due to contract changes, negotiated settlements and claims for unanticipated contract costs	$ 0	$ 0

XML

Inventories - Other Inventory Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Mar. 31, 2023
Schedule of Inventory [Line Items]
Inventories	$ 176,468	$ 186,495
Program Inventory Impairment	44,500
K-MAX®
Schedule of Inventory [Line Items]
Inventory, gross	24,700	25,600
Inventory noncurrent		23,400
SH 2GA Super Seasprite Program
Schedule of Inventory [Line Items]
Inventory, gross	$ 6,200	6,400
Inventory noncurrent		$ 5,300

XML

Goodwill and Other Intangible Assets, Net - Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Goodwill [Roll Forward]
Gross balance at beginning of period		$ 471,719
Accumulated impairment	$ (91,865)	(91,865)
Net balance at beginning of period	379,854
Additions	1,487
Impairments	0
Foreign currency translation	1,163
Net balance at end of period	382,504	379,854
Engineered Products
Goodwill [Roll Forward]
Gross balance at beginning of period		363,785
Accumulated impairment	0	0
Net balance at beginning of period	363,785
Additions	1,487
Impairments	0
Foreign currency translation	1,163
Net balance at end of period	366,435	363,785
Precision Products
Goodwill [Roll Forward]
Gross balance at beginning of period		41,375
Accumulated impairment	(25,306)	(25,306)
Net balance at beginning of period	16,069
Additions	0
Impairments	0
Foreign currency translation	0
Net balance at end of period	16,069	16,069
Structures
Goodwill [Roll Forward]
Gross balance at beginning of period		66,559
Accumulated impairment	(66,559)	(66,559)
Net balance at beginning of period	0
Additions	0
Impairments	0
Foreign currency translation	0
Net balance at end of period	$ 0	$ 0

XML

Goodwill and Other Intangible Assets, Net - Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 443,639	$ 443,145
Accumulated Amortization	(78,212)	(70,814)
Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Gross Amount	363,846	363,549
Accumulated Amortization	(45,025)	(41,695)
Developed technologies
Finite-Lived Intangible Assets [Line Items]
Gross Amount	45,139	45,028
Accumulated Amortization	(18,615)	(17,508)
Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Gross Amount	16,747	16,681
Accumulated Amortization	(3,339)	(3,153)
Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Gross Amount	17,356	17,336
Accumulated Amortization	$ (10,745)	(7,974)
Patents
Finite-Lived Intangible Assets [Line Items]
Amortization Period	17 years
Gross Amount	$ 551	551
Accumulated Amortization	$ (488)	$ (484)
Minimum | Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Amortization Period	6 years
Minimum | Developed technologies
Finite-Lived Intangible Assets [Line Items]
Amortization Period	7 years
Minimum | Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Amortization Period	15 years
Minimum | Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Amortization Period	1 year
Maximum | Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Amortization Period	38 years
Maximum | Developed technologies
Finite-Lived Intangible Assets [Line Items]
Amortization Period	20 years
Maximum | Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Amortization Period	40 years
Maximum | Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Amortization Period	15 years

XML

Pension Plans - Pension plan net periodic benefit costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Qualified Pension Plan
Defined Benefit Plan Disclosure
Service cost	$ (1,450)	$ (800)
Interest cost on projected benefit obligation	7,250	4,250
Expected return on plan assets	(9,550)	(10,525)
Amortization of net loss	1,875	975
Net pension cost (income)	1,025	(4,500)
SERP
Defined Benefit Plan Disclosure
Service cost	0	0
Interest cost on projected benefit obligation	44	22
Expected return on plan assets	0	0
Amortization of net loss	0	15
Net pension cost (income)	$ 44	$ 37

XML

Pension Plans - Contributions (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Qualified Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans
Contributions paid-to-date		$ 0.0
Expected future contributions	$ 0.0
SERP
Defined Benefit Plans and Other Postretirement Benefit Plans
Contributions paid-to-date	0.1	$ 0.5
Expected future contributions	$ 0.4

XML

Commitments and Contingencies (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Loss Contingencies [Line Items]
Notional Value of Contract, Percent	60.00%
Offset Agreement
Loss Contingencies [Line Items]
Notional amount	$ 220.9
Estimate of possible loss	18.8
Contract with Customer, Liability	18.8
New Hartford
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	2.3
Payments for environmental remediation	1.8
New Hartford | Other accruals and payables
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	0.1
New Hartford | Accruals and payables and other long-term liabilties
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	0.5
Bloomfield
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	2.1
Payments for environmental remediation	15.4
Environmental liability	10.3
Estimated remediation liability	$ 20.8
Discount rate (as a percent)	8.00%
Bloomfield | Other accruals and payables
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies, Liabilities, Other Accruals & Payables	$ 0.2

XML

Computation of Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Earnings Per Share Reconciliation [Abstract]
Net (loss) earnings	$ (19)	$ 4,028
Basic:
Weighted average number of shares outstanding (in shares)	28,117	27,950
Basic earnings per share (in usd per share)	$ (0.00)	$ 0.14
Diluted:
Weighted average shares issuable on exercise of dilutive stock options (in shares)	0	132
Diluted (in shares)	28,117	28,082
Diluted earnings per share from continuing operations	$ (0.00)
Diluted earnings per share (in usd per share)		$ 0.14

XML

Computation of Earnings Per Share - Narrative (Details) - shares	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
2024 Notes
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Aggregate shares to be issued upon conversion, convertible	3,056,879	3,056,879
Stock Compensation Plan
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from EPS	698,648	645,403
Equity Securities
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	149,699

XML

Share-based Arrangements - Compensation Arrangements by Share-based Payment Award (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 2,003	$ 2,081
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100.00%	100.00%
Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 2,000	$ 2,100
Restructuring and Severance
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 300

XML

Share-based Arrangements - Stock Options Activity (Details) - Stock Options - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of the period (in shares)	710,782
Granted (in shares)	0
Exercised (in shares)	0
Forfeited or expired (in shares)	(24,061)
Outstanding at end of period (in shares)	686,721
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding at beginning of period, Weighted-average exercise price (in usd per share)	$ 54.51	$ 54.12
Granted, Weighted-average exercise price (in usd per share)	0
Exercised, Weighted-average exercise price (in usd per share)	0
Forfeited or expired, Weighted average exercise price (in usd per share)	43.07
Options outstanding end of period, Weighted-average exercise price (in usd per share)	54.51	$ 54.12
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Per share fair value of options granted (in usd per share)	$ 0

XML

Share-based Arrangements - Restricted Stock Activity (Details) - Restricted Stock Awards	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted Stock outstanding at beginning of the period (in shares) | shares	159,521
Granted (in shares) | shares	102,600
Vested (in shares) | shares	(62,488)
Forfeited or expired (in shares) | shares	(4,366)
Restricted Stock outstanding at end of period (in shares) | shares	195,267
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Restricted Stock outstanding at beginning of period, Weighted-average grant date fair value (usd per share) | $ / shares	$ 45.78
Granted, Weighted Average Grant Date Fair Value (usd per share) | $ / shares	25.24
Vested, Weighted Average Grant Date Fair Value (usd per share) | $ / shares	47.14
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share) | $ / shares	47.51
Restricted Stock outstanding at end of period Weighted-average grant date fair value (usd per share) | $ / shares	$ 34.51

XML

Share-based Arrangements Performance Shares (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100.00%	100.00%
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100.00%	100.00%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Per share fair value of options granted (in usd per share)	$ 0
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	195,267		159,521
Granted (in shares)	102,600
Vested (in shares)	(62,488)
Forfeited or expired (in shares)	(4,366)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 34.51		$ 45.78
Granted, Weighted Average Grant Date Fair Value (usd per share)	25.24
Vested, Weighted Average Grant Date Fair Value (usd per share)	47.14
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share)	$ 47.51
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	320,184		172,144
Granted (in shares)	178,385
Vested (in shares)	0
Forfeited or expired (in shares)	(30,345)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 44.95		$ 60.44
Granted, Weighted Average Grant Date Fair Value (usd per share)	32.03
Vested, Weighted Average Grant Date Fair Value (usd per share)	0
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share)	$ 56.88
Expected option term	2 years 10 months 24 days	2 years 10 months 24 days
Expected volatility	41.20%	39.40%
Risk-free interest rate	4.40%	1.70%
Expected dividend yield	3.30%	1.90%
Per share fair value of options granted (in usd per share)	$ 38.83	$ 68.10

XML

Shareholders' Equity and Accumulated Other Comprehensive Income - Changes in Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Schedule of Capitalization, Equity [Line Items]
Common Stock, Dividends, Per Share, Declared	$ 0.20	$ 0.20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 683,979	$ 796,329
Comprehensive income (loss)	3,609	(428)
Dividends declared (per share of common stock, $0.20 and $0.20, respectively)	(5,627)	(5,590)
Employee stock plans and related tax benefit	495	785
Purchase of treasury shares	(503)	(575)
Share-based compensation expense	2,003	2,081
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	2,538	(5,218)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]		(5,854)
Ending balance	683,956	$ 786,748
Accounting Standards Update 2020-06 Cumulative Effect, Period of Adoption
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	$ 0

XML

Shareholders' Equity and Accumulated Other Comprehensive Income - Accumulated Other Comprehensive Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022	Dec. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 683,979	$ 796,329
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	2,538	(5,218)
Other comprehensive income (loss)	3,628	(4,456)
Ending balance	683,956	786,748
Other Comprehensive Income, Derivative Instruments	(351)	7	$ 0	$ 7
Other Comprehensive Income (Loss), Derivative Instruments, Unrealized Loss / Gain, Tax	78	0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(91)	0
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax	$ 434	$ 228
Common Stock, Dividends, Per Share, Declared	$ 0.20	$ 0.20
Unrealized Gain (Loss) on Cash Flow Hedging Instruments	$ (260)	$ 0
Other Comprehensive Income, Derivative Instruments, Reclassification to Net Income, Tax	28	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	106	0
Other Comprehensive Income, Other, Net of Tax	(351)	0
Total accumulated other comprehensive loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Ending balance	(154,793)	(115,841)
Foreign currency translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(2,071)	8,765
Other comprehensive income (loss)	2,538	(5,218)
Ending balance	467	3,547
Pension and other post-retirement benefits
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent	1,441	762
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(156,350)	(120,157)
Other comprehensive income (loss)	1,441	762
Ending balance	$ (154,909)	$ (119,395)

XML

Income Taxes - Effective Income Tax Rate (Details)	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	20.80%	24.50%

XML

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 24,154,000
Cash, Including Discontinued Operations	us-gaap_CashIncludingDiscontinuedOperations	$ 140,800,000